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ABSTRACT
Significant public demand arises for rapid data-driven scientific investigations us-
ing observational data, especially in personalized healthcare. This dissertation ad-
dresses three complementary challenges of analyzing complex observational data in
biomedical research.
The ethical challenge reflects regulatory policies and social norms regarding data
privacy, which tend to emphasize data security at the expense of effective data shar-
ing. This results in fragmentation and scarcity of available research data. In Chapter
II, we propose the DataSifter approach that mediates this challenge by facilitating
the generation of realistic synthetic data from sensitive datasets containing static and
time-varying variables. The DataSifter method relies on robust imputation methods,
including missForest and an iterative imputation technique for time-varying vari-
ables using the Generalized Linear Mixed Model (GLMM) and the Random Effects-
Expectation Maximization tree (RE-EM tree). Applications demonstrate that under
a moderate level of obfuscation, the DataSifter guarantees sufficient per subject per-
turbations of time-invariant data and preserves the joint distribution and the energy
of the entire data archive, which ensures high utility and analytical value of the time-
varying information. This promotes accelerated innovation by enabling secure sharing
among data governors and researchers.
Once sensitive data can be securely shared, effective analytical tools are needed
to provide viable individualized data-driven solutions. Observational data is an im-
portant data source for estimating dynamic treatment regimes (DTR) that guide
personalized treatment decisions. The second natural challenge regards the viabil-
xi
ity of optimal DTR estimations, which may be affected by the observed treatment
combinations that are not applicable for future patients due to clinical or economic
reasons. In Chapter III, we develop restricted Tree-based Reinforcement Learning to
accommodate restrictions on feasible treatment combinations in observational studies
by truncating possible treatment options based on patient history in a multi-stage
multi-treatment setting. The proposed new method provides optimal treatment rec-
ommendations for patients only regarding viable treatment options and utilizes all
valid observations in the dataset to avoid selection bias and improve efficiency.
In addition to the structured data, unstructured data, such as free-text, or voice-
note, have become an essential component in many biomedical studies based on clin-
ical and health data rapidly, including electronic health records (EHR), providing
extra patient information. The last two chapters in my dissertation (Chapter IV and
Chapter V) expands the methods developed in the previous two projects by utilizing
novel natural language processing (NLP) techniques to address the third challenge
of handling unstructured data elements. In Chapter IV, we construct a text data
anonymization tool, DataSifterText, which generates synthetic free-text data to pro-
tect sensitive unstructured data, such as personal health information. In Chapter
V, we propose to enhance the precision of optimal DTR estimation by acquiring
additional information contained in clinical notes with information extraction (IE)
techniques. Simulation studies and application on blood pressure management in
intensive care units demonstrated that the IE techniques can provide extra patient
information and more accurate counterfactual outcome modeling, because of the po-
tentially enhanced sample size and a wider pool of candidate tailoring variables for
optimal DTR estimation.
The statistical methods presented in this thesis provides theoretical and practical
solutions for privacy-aware utility-preserving large-scale data sharing and clinically
meaningful optimal DTR estimation. The general theoretical formulation of the meth-
xii
ods leads to the design tools and direct applications that are expected to go beyond




There is a significant public demand for rapid data-driven scientific investigations
using observational data, especially in personalized healthcare that accounts for in-
dividual variability. Despite the fact that there are 3.3× 1013 Gigabytes of available
digital content in 2018, less than 5% of the data has been analyzed according to
the International Data Corporation [87, 56]. While translating data into practical
solutions, ethical and practical challenges arise. Specifically, in this dissertation, our
work is motivated by three challenges of analyzing complex observational data in
biomedical research.
The ethical challenge reflects regulatory policies and social norms regarding data
privacy, which hinder efficient data sharing and result in the scarcity of available
data in research. Existing strategies, including differentially private algorithms using
graphical models [99, 12], are not scalable for high dimensional data and are incapable
of handling time-varying data with correlation across time for each subject.
Once sensitive data can be securely shared, analysis tools are needed to provide
viable individualized data-driven solutions. Personalized medicine tailors medical
treatment to the individual characteristics of each patient. Rapid data growth in re-
cent years has made observational data a major data source for personalized medicine.
Dynamic treatment regime (DTR) is a pre-specified sequence of decision-rules that
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guide personalized treatment decisions for patients. A common objective is to use
data to estimate the “optimal DTR,” which optimizes a desired clinical outcome.
A natural challenge arises when some observed treatment combinations are not ap-
plicable for future patients due to clinical or economic reasons, which may lead to
uninterpretable optimal DTR estimations. For example, the DTR may contain re-
called drugs in a particular stage or has a weaker treatment following an aggressive
treatment for nonresponders. In addition, methods do not exist to estimate the best
DTR among predefined feasible treatment combinations. Finally, the traditional ap-
proach of deleting patient records involving inapplicable treatment combinations may
lead to selection bias.
In addition to the structured data, unstructured data such as free-text, or voice
note provides extra information and has become an essential component in many
biomedical data sources, including electronic health records (EHR). The recent suc-
cess in natural language processing techniques has generated much interest in apply-
ing unstructured data analysis methods to biomedical research. However, on the one
hand, there is no existing method to enable safe and rapid sharing of the unstructured
information. Although suppressing names, addresses, dates, and phone numbers is a
common practice in anonymized clinical notes, personal identity information in EHR
can be easily obtained from detailed descriptions in narrative reports. On the other
hand, we notice a lack of research in estimating dynamic treatment regimes using
additional free-text information extracted from clinical notes. Since EHR datasets
are constructed for billing and patient care management, many clinically relevant co-
variates are evident in its narrative contents but are not available in the structured
data.
To address these challenges, in Chapter II, we propose the DataSifter algorithm to
create synthetic data from sensitive datasets containing static and time-varying vari-
ables, which accelerates innovation by enabling secure synthetic data sharing among
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data governors, researchers, and trainees. The DataSifter method relies on robust
imputation methods, including missForest and an iterative imputation technique for
time-varying variables using the Generalized Linear Mixed Model (GLMM) and the
Random Effects-Expectation Maximization tree (RE-EM tree). Applications based
on simulated and real clinical data demonstrate the balance between the preserva-
tion of the data utility (analytical value) and the reduction of re-identification risk
(privacy) associated with sharing obfuscated data. Our extensive simulation shows
that under a moderate level of obfuscation, in addition to guaranteeing per subject
obfuscation of time-invariant data, DataSifter also protects sensitive information in
the time-varying records without a substantial impact on the analytical value of the
sifted dataset.
To solve one of the technical challenges and provide viable treatment regimes,
in Chapter III, we develop the Restricted Tree-based Reinforcement Learning to ac-
commodate restrictions on feasible treatment combinations in observational studies
by truncating possible treatment options based on patient history in a multi-stage
multi-treatment setting. Such constrained optimization procedure is conducted back-
ward from the last treatment stage so that patients in the restricted arms can still
contribute to some of the stage-wise optimal regime estimations when their history
up to that stage is considered feasible. Our algorithm provides optimal treatment rec-
ommendations for patients regarding viable treatment options and utilizes all valid
observations in the dataset to avoid selection bias and improve efficiency.
With extra information in unstructured EHR data, we can refine the previous
solutions. Chapter IV and Chapter V elevate the previous two chapters by utilizing
novel techniques in natural language processing. In Chapter IV, we construct a free-
text data anonymization tool – DataSifterText, which offers synthetic free-text data
that protects patients’ Protected Health Information (PHI). According to our clinical
data applications, the proposed technique protects the distribution of the original
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text corpus, offers individual level data obfuscation, and enables collaborative data
analytics without compromising personally identifiable information. The DataSifter-
Text algorithm provides sufficient privacy protection by disguising the location of true
and obfuscated tokens. In Chapter V, we enhance the precision of optimal DTR es-
timation with extra information in clinical notes. Simulation studies and application
on blood pressure management in intensive care units demonstrated that utilizing
information extraction (IE) techniques in DTR estimations enables clinical decision
support for larger study populations, provides more accurate counterfactual outcome
modeling, and supports a wider pool of candidate tailoring variables.
The main contributions of this dissertation include (1) the creation and implemen-
tation of the partially synthetic data publishing tool DataSifter, which handles static
and time-varying data (Chapter II). (2) The development of the Restricted Tree-based
Reinforcement Learning for accommodating restrictions on feasible treatment com-
binations in observational studies when estimating optimal DTRs (Chapter III). (3)
The extension of the DataSifter algorithm to unstructured data obfuscation (Chapter
IV), and (4) the application of IE techniques in optimal DTR estimations (Chapter
V). The proposed methods enable collaborations to expedite bench-to-bedside trans-
lational research and improve the precision of healthcare management. The overall
structure of the dissertation is illustrated in Figure 1.1.
4
Figure 1.1: Dissertation Flowchart
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CHAPTER II
DataSifter: Statistical Obfuscation of Sensitive
Datasets
2.1 Introduction
Open science advocates the sharing of data, methods, source-code, end-to-end
protocols, computational services, and peer-reviews. The benefits of open science on
many aspects of common human experiences are well documented [54, 86, 48, 8, 14].
Along with the well-known exponential increase of the amount of newly acquired data,
there is also an equally sticking exponential decay of the value of data that is stored
but not processed, shared, or augmented [19, 79]. However, sharing data without
loss of privacy is difficult, especially in the medical and healthcare settings. In fact,
66% of the participants in the 2017 Health Information National Trends Survey were
concerned about data privacy when health information is electronically exchanged
[52].
For data sharing involving Protected Health Information (PHI), organizations’
Institutional Review Boards (IRBs) need to review the research before the required
information can be retrieved from existing medical records and processed to extract
valuable information. IRB’s initial review process may take up to 4 months, however
this process has significant variability depending on the type of review, e.g., expedited,
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exempt, or full board reviews may take additional time, from 16 to 631 days [30]. In
the United States, healthcare systems own the property rights for Electronic Health
Records (EHR), and researchers have to bear the costs of data extraction and transfer
under data use agreements [7].
Such regulation guarantees the protection of individual privacy rights, but de-
lays researchers’ abilities to gain access to appropriate information, build models and
rapidly validate scientific discovery, which slows the knowledge transfer and basic
science translation into clinical practice. The resulting slow and restricted data ac-
cess may limit data utility for answering specific scientific questions. For example, in
2015, Keegan et al. [37] examined the relationship between ethnicity and short-term
breast cancer survival using 2010 Kaiser Permanente Northern California EHR data.
However, to obtain both the demographics and the cancer treatments for patients
across facilities, they had to reduce the study cohort time frame from 8 years to 3
years in order to have both datasets available and link them together, which signifi-
cantly impacted the statistical power of this scientific investigation. Thus, there are
enormous benefits in developing new statistical methods to facilitate secure and quick
information exchange between data stewards and data science experts.
Three existing strategies provide secure mechanisms for modeling, processing, and
interrogating sensitive cross-sectional data. These include secure enclave access, data
encryption (e.g., fully homomorphic encryption), and synthetic data publishing. Se-
cure data enclave environments [1, 32] offer a platform for researchers to analyze
sensitive data without compromising risks for misuse, fraud, and other violations.
Many health information storage solutions, e.g., EHRs, rely on technology that pro-
vides managed data access for research in safe and controlled environments [68]. A
number of possible unmodified database management systems (DBMS) can be utilized
to provide secure data enclaves [2, 5]. Second, data encryption methods, including
Fully Homomorphic Encryption (FHE), encode the data to allow computations di-
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rectly on the resulting ciphertext [35, 26, 96]. FHE relies on homomorphic computing
(result-preserving property) on the ciphertext without exposing the sensitive raw data
to independent researchers, analysts, or data scientists. The above two mechanisms
provide secure channels for data transfer and storage, but do not shorten the data
sharing process.
In response, the third strategy, synthetic data generation emerged, which was first
proposed by Rubin 1993 [70] with two classes of generating methods, as summarized
by Reiter and Raghunathan [59]. The fully synthetic data sets are created by condi-
tional distributions estimated from sensitive datasets. Popular methods for construct-
ing these conditional distributions include Bayesian network [99], graphical models
[12] and multiple imputation (MI) [70, 55]. However, these solutions are not scalable
for sensitive datasets with higher dimensions (larger number of records and variables),
especially given that variable selection can be burdensome for parametric models and
greedy searches for causal nodes in graphical models are computationally expensive
with too many candidates. Partially synthetic data refers to a set of multiple-imputed
data replacing sensitive data value cells with imputations [42, 57, 58]. This class of
methods treats data obfuscation as a missing data handling problem, where they
generate artificial missingness for sensitive values in the dataset and impute the value
with the remaining untouched data. As a result, partially synthetic data provides
valid statistical inference. However, combined information from a set of multiple im-
puted datasets indicates the locations of true and obfuscated cells resulting no privacy
protection for the true cells. In practice, covering all possible sensitive values is barely
achievable and selecting the obfuscation location is a subjective and critical step for
data privacy protection.
To promote effective data sharing, we propose the DataSifter frame work, which
is designed to help data governors safely publish synthetic subsets of their sensitive
dataset or share deidentified data (with certain level of obfuscation) that enable spe-
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cific types of data analysts. Under the proposed framework, the trade-off between
data privacy and information utility determines the level of obfuscation associated
with partially synthetic data generation. We define data privacy as the disclosure risk
of specific data values given an intruder’s prior knowledge and published synthetic
data. Given a predefined inferential model and some specific clinical or research
questions, data utility is the analytical value of the data measured by the deviation
of the model inference based on the original and the partially synthetic datasets.
Multiple imputation (MI) methods are designed to minimize the loss of data utility
while the DataSifter framework focuses on maximizing the data privacy protection
under acceptable data utility. In this chapter, we will evaluate the quality of partially
synthetic datasets based on the above two criteria.
We developed the first generation of the DataSifter technique (DataSifter I) [45]
that handles high dimensional cross-sectional data. Perturbing individual level records,
it allows researchers to securely acquire population level information that closely ap-
proximates the true signal. The core DataSifter technique relies on two processes
supporting the critical statistical obfuscation of the data. First, it randomly and arti-
ficially generates missingness in the data, following the Missing Completely At Ran-
dom (MCAR) mechanism [69], and uses robust iterative imputation methods, e.g.,
missForest [80], to approximate the original information. Second, DataSifter I classi-
fies neighboring cases (similar observations) using Euclidean and Gower distances for
continuous and categorical variables, respectively. Within each neighborhood clus-
ter, DataSifter I randomly swaps a subset of feature values between similar records.
This second operation guarantees partial change for each record while preserving the
geometrical information on the data in feature space.
However, time-varying correlated data cannot be processed by DataSifter I, while
such data, including longitudinal data, are ubiquitous and provide important informa-
tion for many biomedical and health conditions. For example, in EHR databases, pa-
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tient characteristics and disease progression variables are collected repeatedly across
visits. Maintaining or preserving the within-subject covariance structure among time-
varying measurements presents another layer of challenges. Currently, there are no
automated procedures that enable secure sharing of time-varying correlated data
with sensitive information. The proposed new algorithm, DataSifter with Time-
varying Correlated Data (DataSifter II), extends the DataSifter functionality in the
case of dealing with large, cross-sectional, time-varying, and self-correlated data ele-
ments. DataSifter II introduces artificial missingness and embed robust longitudinal
imputation methods to handle high dimensional sensitive data with time-varying
measures. As illustrated in Figure 2.1, our proposed procedure operates on the
time-varying data separately from the time-invariant (cross-sectional) data elements
and then integrates the two parts to compile the obfuscated sifted dataset (output).
DataSifter II preserves the data utility while introducing a proper level of privacy
protection. The newly developed DataSifter II R package is available on GitHub
https://github.com/SOCR/DataSifterII. With the proposed algorithm, data gov-
ernors can create and validate sifted data objects with time-varying components prior
to their release or sharing, allowing user-defined secure level and protecting the orig-
inal within-subject covariance structure.
The rest of the manuscript is organized as follows: in Section 2.2, we introduce the
DataSifter I procedure, evaluate its performance under different simulation settings
using simple metrics and apply the algorithm to ABIDE dataset. In Section 2.3.1
we formally define the data privacy and utility measurement for partially synthetic
data evaluation. Specifically, in section 2.3.1.2, we define the disclosure risk and
show that partially synthetic datasets generated by the DataSifter framework provide
better privacy protection than that of the MI method. Section 2.3.2 describes the
DataSifter II protocol. Section 2.3.3 validates the data utility preservation and privacy
protection of the proposed algorithm under different simulation settings and compares
10
Figure 2.1: Graphical workflow depicting the organization of the DataSifter technique.
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the performance against the MI method. In Section 2.3.4, we apply DataSifter II to
the MIMIC-III clinical data and demonstrate its performance in maintaining a careful
balance between protecting sensitive information and preservation of the data utility.
We summarize the findings and discuss the expected impact and future developments
in Section 2.4.
2.2 DataSifter I: Partially Synthetic Time-invariant Data Gen-
eration
2.2.1 DataSifter I Overview
The core of the DataSifter I is an iterative statistical computing approach that
provides the data-governors controlled manipulation of the trade-off between sensitive
information obfuscation and preservation of the joint distribution. The DataSifter I
is designed to satisfy data requests from pilot study investigators focused on specific
target populations. The DataSifter I handles high dimensional data with various of
data elements including multiple numerical or categorical features and one unstruc-
tured variable. However, the obfuscation of the unstructured variable is simply done
by reallocating the free-text documents in the swapping step. The content of the text
is not being altered to protect privacy. A more sophisticated method dealing with
unstructured data can be found in Chapter IV.
At each step, the algorithm generates instances of complete datasets that in ag-
gregate closely resemble the intrinsic characteristics of the original cohort; however,
at an individual level, the rows of data are substantially obfuscated. This procedure
drastically reduces the risk for subject re-identification by stratification, as meta-data
for all subjects is randomly and repeatedly encoded. Probabilistic (re)sampling, dis-
tance metrics and imputation methods play essential roles in the proposed DataSifter
I obfuscation approach. In regard to the designed data requests, the main assump-
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tions of the DataSifter I technique include: (A1) Incomplete observations are driven
by missing at random (MAR) or missing completely at random (MCAR) mechanisms
[41]; (A2) The utility of each feature is equally important; (A3) Large random sam-
ples of the original data preserves the overall joint distribution. These assumptions
are standard and allow us to manage the data or quantify data utility. (A1) allows
accurate imputations (A2) is essential in calculating subject-pair distances, and (A3)
promotes subject-wise parallelization. We use the following framework to form the
DataSifter I algorithm. Three sources of obfuscation have been applied to the data
during the DataSifter I technique: (1) initial data imputation (in the preprocessing
step), (2) artificially create and impute missingness (in the imputation step), and (3)
swapping data values in the neighborhood (in the obfuscation step). Here we define
all the mappings that has been employed for obfuscation.
2.2.2 Notation
Define X as the counterfactual complete sensitive dataset for sifting consisting m
features and n cases. Let’s use 1 ≤ j ≤ m to denote features and 1 ≤ i ≤ n to denote
cases:
Xj = (X1, ..., Xj, ..., Xm) ∈ Rn×m, Xj = (X1,j, ..., Xn,j)T , 1 ≤ j ≤ m.
In the above expression, Xi,j denotes the i
th subject’s jth feature value. We define the
utility information embedded in a dataset as the knowledge about the joint distribu-
tion of the holistic data including all variables. By preservation of utility, we mean
the relative conservation of the signal energy that suggests small deviation of the
sifted-data joint distribution from the original (raw) data joint distribution. Clearly,
this does not hold true for large obfuscation levels.
Missing data is pervasive in almost all real-world datasets. We define the hypo-
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thetical complete j-th feature as:
Xj = (Xobs,j, Xmis,j),
where Xmis,j denotes a vector containing the actual values of the missing data portion.
What we observe is denoted as X̃j = (X̃obs,j, Nj),here Nj represents the missing cells.
The length of X̃obs,j is nj and the length of Nj is n− nj.
2.2.3 User-controlled Parameters
Sifting different data archives requires customized data management. Five specific
parameters mediate this management:
k0: A binary parameter indicating whether or not to obfuscate the unstructured
feature, if any.
k1: The percent of artificial missing data values that should be artificially in-
troduced prior to imputation. Missingness is stochastically introduced to all data
elements except the unstructured variable. The range of this parameter can be be-
tween 0 and 0.4. We set an upper bound of 40% missingness in order to keep the
remaining dataset informative.
k2: The number of times to repeat the introduction-of-missing-and-imputation
step. Five options are available from 0 to 4.
k3: The fraction of structured features to be obfuscated in all the cases. Available
options can vary between 0 and 1.
k4: The fraction of closest subjects to be considered as neighbours of a given
subject. This implies that the top k4×100% of the closest-distance subjects of a
given subject can be considered as candidates for its neighbours. Then, the final
neighbouring status of any subject is determined by an additional hard cut off.
Table 2.1 illustrates the combinations of ki parameters implemented in the al-
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gorithm to accommodate the user defined balance between privacy protection and
obfuscation. The level of obfuscation spans the range from raw data (no obfuscation)
to synthetically simulated data (complete obfuscation). Our highest level of obfusca-
tion, i.e. ‘indep’, refers to the synthetic dataset sample from the marginal empirical
distributions of all the features.
Table 2.1: DataSifter I k parameter vector mapping determining the level of obfus-
cation.
Obfuscation level k0 k1 k2 k3 k4
None 0 0 0 0 0
Small 0 0.05 1 0.1 0.01
Medium 1 0.25 2 0.6 0.05
Large 1 0.4 5 0.8 0.2
Indep Output synthetic data with independent features
2.2.4 Preprocessing
The preprocessing steps of the original data might vary for different datasets.
Figure 2.2 illustrates the procedures included in the DataSifter I preprocessing step.
The overall goal is to delete uninformative features with a constant value or have
too much missingness and impute missing values in the original data. To impute the
missing values, we use a non-parametric imputation method missForest [80], albeit
many alternative strategies are also possible. As an iterative non-parametric impu-
tation method of mixed data types, missForest fits a random forest model for each
feature separately during one iteration using the observed data as training data and
provide predictions for the missing cells. Hence, the random forest model for imput-
ing a specific column uses all other variables in the dataset as predictors. In each
iteration, the imputation of the entire dataset starts in the column with least missing
values and ends in the column with most missing values. It stops to iterate when the
difference between the latest and prior imputed data matrix is at least as great as the
previous difference measured or the maximal iteration limit achieves. The difference
15


























k is the imputed vector and X̂
(r)
ik is the imputed value for subject i of the
kth variable in the rth iteration. We choose missForest algorithm, rather than other
model-based multiple imputation methods, for the following reasons: (1) missForest
employs random forest imputation that can cope with complex EHR data, which
typically involves mixed-type data, complex interactions, and non-linear relations;
(2) it relies on limited modeling assumptions; and (3) it is relatively efficient for
large-scale and high-dimensional data.
DataSifter I produces a complete dataset after the preprocessing step. For sim-
plicity, we denote n as the number of subjects in the dataset, k as the number of
informative features filtered by the preprocessing step, and M as the number of sub-
jects per batch during the parallel process. Alternative preprocessing methods are
possible as long as the aims are met.
2.2.5 Imputation Step
Following the data preprocessing, the DataSifter I continues with the imputa-
tion and the obfuscation steps. During the imputation step, the DataSifter I algo-
rithm first introduces random artificial missing values to the complete dataset, which
synthetically provides privacy protection. The artificial missingness obeys missing
completely at random (MCAR) mechanism as the missingness is introduces stochas-
tically for case and feature indices [41]. Assume we have n entries of data and denote
Y = (Yobs,Ymis) as the full data, where Yobs represents the observed part and Ymis
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Figure 2.2: Flow Chart for Preprocessing Step.
the missing part. Let R denote the missing indicator with Ri = I(Yi ∈ Ymis) for
i = 1, 2, .., n. Because the MCAR assumption is satisfied, we have the following
relationship: P (R|Y) = P (R).
This relationship between observed and missing values guarantees that the fully
observed data represents a random sample of the complete data. Accurate imputa-
tions of the missing values based on the observed values can be obtained with robust
imputation methods. Thus, as described above, the introduction of missing data
has limited effect in altering the joint distribution of the data during the imputation
process. Similar to the preprocessing step, we use the missForest [80] to impute the
artificial missingness with modified stopping criteria. Since the true missing value is











mis,k denotes the imputed values at r
th iteration.
Following the imputation step, the outputted “sifted” dataset, Xwork, has the
following properties: (1) individual cases are manipulated, yet complete, protecting
individual privacy, since hackers cannot distinguish “true” values from imputed values
that are in the same format; (2) subjects with introduced missingness can still play
an important role in the analysis after the imputation.
2.2.6 Obfuscation Step
During the obfuscation step, the DataSifter I repeatedly swaps the unstructured
feature value and randomly selected structured feature values based on the closest
neighbours to ensure a balance between data privacy and preservation of the feature
distributions. The algorithm relies on distance metrics to determine neighbourhoods
for all cases [24,25] and swaps feature values between closely adjacent neighbouring
pairs. We compute pair-wise distances between all cases using a weighted distance
measure: (1) Euclidean distances for normalized numerical features, and (2) Gower’s
distance for categorical features [28]. To obtain the distance matrix, we divide the
current dataset outputted by the imputation step into three subsets and re-index the
elements as numerical subset Xnum = (~x1, ~x2, ..., ~xl) = (x̂1, x̂2, ..., x̂n)
T , categorical
dataset Xcat = (~y1, ~y2, ..., ~yp−1−l) = (ŷ1, ŷ2, ..., ŷn)
T , and the unstructured feature
Xunstr, where we have l numerical features, p − 1 − l categorical features and one
unstructured feature. For Xnum, we apply a map algorithm f , which calculates the
Euclidean distance for every pair of cases and maps the input data metric to the target
distance metric. f : Rn×l → Rn×n is defined below. For X = (x1, x2, ..., xn)T , f(X) =




maxi,j{‖xi−xj‖2}−mini,j{‖xi−xj‖2} , i < j
0 , otherwise
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∀i, j. We utilize f to obtain f(Xnum) = DE = (eij)n×n. For the categorical subset, we
define the mapping algorithm g which calculates the distance for categorical features
via Gower’s rule. For X = (x1, x2, ..., xn)






Here, gijs is an indicator function related to the s
th feature, which is defined as,
gijs =
 0 , xis = xjs1 , xis 6= xjs .
Similarly, for Xcat = (~y1, ~y2, ..., ~yn), we attain DG = (gij)n×n = g(Xcat). Under
assumption (A2), we weigh the distance and obtain the complete paired-distances
metric,







where l/p and (p − 1 − l)/p represents the weights for the Euclidean and Gower
distances, respectively. Two criteria are used to determine the neighboring status
for subject pairs: (1) Closest k4 × n neighbors regarding the pair distances; and
(2) a hard cut off. In distance matrix D, for each i, we rank the paired distances
dij as {di1, di2, ..., din}. Then, we find the maximum distance of the top k4 ∗ 100%
di,floor(k4×n), where floor(k4 × n) rounds the number of cases to select to the lower
integer. We use the cutoff to identify the potential neighbors of the ith individual:
neighbor(i) = {(i, j) : dij < di,floor(k4×n)},∀i = 1, ..., n.
In addition, we set up a criterion to narrow the neighborhood. Let
c = inf{dij}+ sd{dij}.
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Figure 2.3: Flow Chart for Imputation and Obfuscation Steps.
Here, sd{dij} refers to standard deviation of all the dij’s in D. We only preserve the
neighbors that satisfy dij ≤ c. The final set of neighbors, i.e. neighborfinal, is defined
as follows:
neighborfinal(i) = {(i, j)|(i, j) ∈ neighbor(i), dij ≤ c},∀i = 1, ..., n.
For extreme subjects that have no neighbors selected by the above process, we
do not apply the obfuscation step. One subject could have multiple neighbors. For
every subject, a neighboring subject is randomly selected as its swapping partner.
We randomly swap a subset of randomly chosen features among each swapping pair.




In this section, we define Xstr as the structured feature subset of current data,
which consists of Xnum and Xcat. Also, Rand(X, r) is a function that randomly picks
r elements without replacement in set X.
Input:
(1) The dataset after preprocessing Xwork = (~x1, ~x2, ..., ~xp) ∈ Rn×p with n cases
and p features. There are one unstructured and p−1 structured features in the dataset.
After the preprocessing step, p is less than or equal to the number of features in the
original dataset. Each ~xi is a column vector, ~xi = (x1i, x2i, ..., xni)
T , i = 1, ..., p
(2) The categorical level of obfuscation L=“none”, “small”, “medium”, “large”,
“indep”, or alternatively a specific parameter vector (k0, k1, k2, k3, k4).
Special cases:
If L =’none’, the output is Xwork and if L =’indep’, the output is dented by Xnew.
Each feature in Xnew is a synthetic sample from the empirical distribution of the
corresponding feature in Xwork.
Algorithm 1 DataSifter I
1: for i in 1 : k2 do
2: Introduce k1 × n× (p− 1) missing values to Xstr.
3: Impute missingness (e.g., via missForest) and update Xwork.
4: end for
5: if k0 = 1 then
6: for i = 1 : n do
7: (i, j) = Rand(neighbor∗(i), 1)
8: Swap the unstructured value for the pair (i, j) in Xwork
9: end for
10: end if
11: for i = 1 : n do
12: j = Rand(neighbor∗(i), 1)
13: Zi = Rand({1, ..., p− 1}, k3 × (p− 1)) = zi,1, ..., zi,k3%×(p−1)
14: for t ∈ Zi do






We present three different simulation studies to demonstrate the performance of
the DataSifter I algorithm and assess its capability to (1) obfuscate and guard against
stratification attempts for re-identification and (2) manage the overall data structure
and preserve useful information in the resulting “sifted” data. In all experiments,
we use n = 1, 000 as number of subjects. In the first simulation, a binary outcome
(Y ) and five covariates (Xi, i = 1, ..., 5) were simulated; X1 to X4 were independently
generated by normal distributions with the following distribution specifications:
X1, X2 ∼ N(0, 1), X3 ∼ N(−1, 1), and X4 ∼ N(0, 2).
The binary variable X5 was directly dependent on X1 and X2: logit(X5i) = 0.5−
4X1i −X2i. The binary outcome variable was generated as follows:
logit[P (Yi = 1|X)] = 10 + 10×X1i + 10×X2i − 5×X3i − 20×X4i − 15×X5i + εi,
where the residuals were independent and identically distributed (iid) namely εi ∼
N(0, 1), i = 1, .., n. Missingness for X1 and X2 was then introduced based on X5 to
meet the MAR criteria, which mimicked the real data situation. Denote Xi,1mis =
I(Xi1 = NA) and Xi,2mis = I(Xi2 = NA), where i is the subject indicator. Missing-
ness was introduced using the following probabilities:
P (Xi,1mis = 1) = P (Xi,2mis = 1) =

0.193, if X5 = Y = 0
0.060, if X5 + Y = 1
0.003, if X5 + Y = 2
As mentioned earlier, in the Imputation section, we can impute the original missing
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values in the dataset prior to applying the subsequent DataSifter I algorithmic steps.
The second simulation demonstrates an example of count outcomes. A Poisson model
was used to generate the data.
P (Yi = n) = (λ
n
i )/n!× e−λi ,
where
log(λi) = 0.2 + 0.5 ∗X1 + 1 ∗X2 − 0.5 ∗X3 − 1 ∗X4 − 1.5 ∗X5 + εi,
with iid residuals εi ∼ N(0, 1). The covariates Xi, i = 1, ..., 4 were generated using
uniform distributions. We constructed X5 based on X1 and X2 and used a similar
strategy as in the first binary simulation to introduce missingness. The third simu-
lation involves continuous outcomes, where the response Y is generated by a similar
linear model as in the first experiment; however, it uses an identity link yielding a
continuous outcome:
Y = 10 + 10 ∗X1 + 10 ∗X2 − 5 ∗X3 − 20 ∗X4 − 15 ∗X5 + εi.
Again, the residuals were iid εi ∼ N(0, 1). All covariates were generated from uniform
distributions and the missing patterns were stochastically determined as in the first
binary experiment. For all simulation studies, we focused on verifying whether the
“sifted” datasets preserve a certain level of the energy that was present in the original
true signals, relative to null signals. In addition, we examined the trade-offs between
the level of obfuscation and the residual value (utility) of the resulting “sifted” data
as a measure of the algorithm’s performance. To make all three simulations more
realistic, we augmented the original outcome and the (real) five covariates, with 20
additional null features that acted as decoy or “noisy” control features. All 20 null
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features were uniformly distributed with various ranges and were independent of the
outcome.
For each simulation, we derived 30 “sifted” datasets under a range of privacy levels,
from “none” to “indep” level of obfuscation. To assess the privacy protection ability,
we measured the Percent of Identical Feature Values (PIFV) between the “sifted”
outcome and the original data for all the cases under each obfuscation level, i.e., we
compared each subject’s original and “sifted” records and measured the ratio between
the number of identical values over the total number of features. For determine utility
preservation, we used regularized linear models, with an elastic net regularization
term, to identify the salient variables. Internal 10-fold statistical cross-validation
was used to validate the results of the elastic net feature selection. Let X denote
the covariate matrix (subjects × features =1,000 × 25), y denote the outcome, and
β denote the elastic net parameter estimates obtained by optimizing the following
objective function. We have
β̂enet = argminβ(y −X)T (y −X) + λα‖β‖2+(1− α)‖β‖2,
where α is the parameter to determining the blend of the LASSO and Ridge con-
tributions to the penalty, and λ is the regularization penalty parameter [100]. In
our experiments, we used α = 0.8 giving a slight dominance to the LASSO penalty.
A regularization parameter tuning procedure was also performed, using misclassifica-
tion error rate for binary simulation, deviance for count simulation, and mean squared
error for continuous simulation. The largest λ value, which is within one standard
error of the minimum cross-validated error, was selected as the optimal parameter
[24]. When the estimated coefficient was different from zero, we considered this ev-
idence that the corresponding feature represented a “true” predictor. On the other
hand, zero coefficient estimates corresponded to “false” predictors. Recall that in all
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simulations, there were five true predictors and 20 null variables. The true positives
(number of true features identified) and the false positives (number of null features
identifies as true predictors) were recorded for all experiments and each privacy level.
2.2.8.2 Simulation Results - Protection of sensitive information (privacy)
The privacy protection power relies heavily on the user-defined privacy level and
the intrinsic information structure. Our results showed that for high privacy levels,
PIFVs were close to 0% for all numerical features. For datasets including categorical
features, the algorithm provided PIFVs similar to the lowest PIFV between any pair of
different subjects in the original dataset. The overall privacy protection performance
of the DataSifter I was excellent. Based on the overall simulation performance, a
default recommended privacy level may be set at “medium.” However, this is also
subject to the sensitivity of the data, the specific characteristics of the data, and the
trustworthiness of the data requestor. Figure 2.4 illustrates the relationship between
PIFVs for the synthetic datasets and user-defined privacy levels. The outcome labels
“binary”, “count”, and “continuous” refer to the first experiment, second experiment,
and third experiments, respectively. As expected, the graph shows that preservation
of sensitive information is better protected when the privacy level is higher. For all
three simulations, the DataSifter I had similar performance in terms of PIFV. The
outliers in the “none” level resulted from imputation of originally missing values.
When the obfuscation was set at “medium”level, the variance of the PIFV was the
largest as the levels of obfuscation might differ among individuals when using random
sampling. “Small” level of obfuscation manipulated less of the data, with limited
range around the neighborhood of each case. Hence, it generated smaller PIFV
variances among individuals. On the other hand, “large” obfuscation level had small
variance for PIVF as it changed most of the features for all cases. Under the “large”
obfuscation setting, PIFV was around 25% for all three experiments, which provided
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Figure 2.4: Boxplots of Percent of Identical Feature Values (PIFV) under Different
Privacy Levels. Binary outcome refers to the first experiment; Count refers to the
second experiment; Continuous refers to the third experiment. Each box represents
30 different “sifted” data or 30,000 “sifted” cases.
reliable protection for patient privacy. Under the “medium” level, around 75% of the
cases had more than 50% of their data elements different from their original (true)
counterparts. The synthetic data under “indep” changed almost all the feature values
for every subject. Remember that these five original obfuscation levels represent
simple examples of specifying the 5D Data-Sifter-control parameter vector k.
2.2.8.3 Simulation Results - Preserving utility information of the original
dataset.
Next, we assessed the DataSifter I algorithm’s integrity, in terms of its ability
to maintain utility information, i.e., preserve the energy or information content of
the original data. A detailed explanation can be found in section 2.2.2. Our re-
sults suggest that up to moderate obfuscation levels, the algorithm maintains a fair
amount of information (data energy). However, as expected, this ability fades away
for larger obfuscation levels. Also, different k parameter vectors have varying effects
on the overall utility preservation. The results illustrating the DataSifter I ability to
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conserve the data energy are illustrated in Figure 2.5. We report the true positive
(TP) and false positive (FP) number of feature selections for the three simulation
experiments. These results showed that the DataSifter I is able to preserve the signal
energy in the original data. As expected, and in contrast to the privacy preservation
ability, the performance of the technique to maintain data utility is better under low
obfuscation levels. Different outcome types also affect the utility preservation. The
simulations show that information energy preservation in the continuous outcome
case is slightly better, compared to binary and count outcomes. In the continuous
outcome simulation, for obfuscation levels below “large”, regularization and variable
selection via elastic net successfully identified all five important predictors in almost
all “sifted” datasets, and the number of false positives was mostly zero. In addition,
the variations of TPs and FPs among different privacy levels was the smallest among
the three simulation experiments. The count outcome simulation performed similarly
well; under “medium” obfuscation, elastic net was able to select 3 out of 5 features
over 75% of the times. Count outcome simulation was not always stable. For instance,
some datasets undergoing extreme “sifting” had zero true features selected; however,
the algorithm also kept low the false negative rate. The binary outcome simulation
demonstrated the least utility preservation as it had the highest false positive rates
and the largest variability among all settings. Based on Figure 2.5, there is almost
no true signal, or false signal, captured in the synthetic “indep” setting, which re-
sults from the elimination of the correlations among features. The extreme “indep”
case aims to achieve maximum protection for patient privacy. As a consequence, the


















































Figure 2.5: Logistic Model with Elastic Net Signal Capturing Ability. TP is the
number of true signals (total true predictors = 5) captured by the model. FP is the
number of null signals that the model has falsely selected (total null signals=20).
2.2.9 Clinical Data Application: Using DataSifter I to Obfuscate the
ABIDE Data
We demonstrate the functionality of the DataSifter I on the Autism Brain Imag-
ing Data Exchange (ABIDE) dataset [18]. The ABIDE dataset represents a multi-
institutional effort for aggregating and sharing the imaging, clinical and phenotypic
data of 1,112 volunteers [18]. The data includes resting-state functional magnetic
resonance imaging (rs-fMRI) structural MRI, and phenotypic information of 539 pa-
tients (autism spectrum disorder) and 573 age-matched asymptomatic controls. In our
study, we selected a subsample of 1,098 patients including 528 ASD and 570 controls.
The dataset has 500 structural MRI biomarkers and phenotypical information such
as age, sex and IQ. It is a very challenging case-study due to the heterogeneity of the
data, format of the data elements, and the complexity of mental health phenotypes.
We use the ABIDE data to showcase the performance of the DataSifter I technique on
a convoluted multiplex study. The ABIDE dataset comprises 1,098 patients and 506
features. We included one unstructured feature-“image data file name” (“Data”) in
the dataset to show the DataSifter I ability to obfuscate unstructured text elements.
Resembling the simulation experiments, we built a dataSifter() function that has
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five different levels of obfuscation to demonstrate the obfuscation utility trade-off.
Obfuscation was assessed using PIFV as the simulation studies. We applied random
forest [40] to predict the target binary outcome autism spectrum disorder (ASD) sta-
tus (ASD vs. control) as a proxy of the algorithm’s utility to maintain the energy
of the original dataset into the “sifted” output. Predictions of the ASD status was
conducted with the randomForest package. When specifying the parameters in the
dataSifter() function, level of obfuscation can be set by level. Here we used five
different obfuscation levels. The level of obfuscation can be alternatively specified us-
ing a set of k combinations as function arguments. For example, to perform “small”
obfuscation level, we can specify k0 = 0, k1 = 0.05, k2 = 1, k3 = 0.1, k4 = 0.01 in the
dataSifter() function, which creates a flexible way to manage obfuscation levels. In
this study, as mentioned above, the unstructured variable was named as “Data”. If
there are no rich text variables, the set of unstructured.names can be left to default
(i.e., NULL). Explicit sensitive information like the subject ID, i.e., subjID column,
needs to be removed from the original dataset in advance. The batch size for the algo-
rithm is defined by the parameter batchsubj. As mentioned in the Methods section,
the DataSifter I algorithm operated on batches to provide scalability and alleviate
the computational complexity. We recommend using a relatively small batchsubj and
large number of cores for datasets with a huge number of cases (e.g., hundreds of
thousands). The maximum number of iterations for the missForest imputation al-
gorithm is set to one to minimize the computational cost determined by imputing a
large number of features. We obtained five “sifted” output datasets corresponding
to different obfuscation levels: no (“none” obfuscation), s (“small” obfucation), m
(“medium” obfuscation), l (“large” obfuscation), and i (“indep” synthetic data from
empirical distributions of each feature). We then inspected the obfuscations made
to the original dataset. Boxplots for PIFV was then plotted in Figure 2.6 A to


























































Figure 2.6: Boxplots of PIFVs for ABIDE under different levels of DataSifter I ob-
fuscations. Each box represents 1,098 subjects among the ABIDE sub-cohort.
obfuscation. Comparing the application with the simulation experiments, the algo-
rithm works better with a larger number of features. Under “medium” obfuscation
level, the algorithm achieved 50% and 25% PIVF for the binary simulation data and
ABIDE data, respectively.
To assess the utility information, we use the “sifted” datasets as training sets to fit
random forest. These trained models provided predicted values for 632 complete cases
in the original ABIDE data. The random forest built using no dataset predicted all
outcomes correctly. s, m, l and i datasets were able to provide predictions with 98%,
70%, 52% and 54% accuracy, respectively. The prediction accuracy of all the datasets
are illustrated in Figure 2.6 (B). Again, this result shows the trade-off between utility
and the user-controlled privacy levels.
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2.3 DataSifter II: Partially Synthetic Time-varying Data Gen-
eration
2.3.1 Privacy and Utility Measurement for Partially Synthetic Data
2.3.1.1 Data Structure and Notations
Time-varying correlated data are common in most biomedical and epidemiology
studies. For example, in multi-center studies, we typically measure the target vari-
ables across all subjects at a single time point, but the subjects may be correlated
within each center. In longitudinal data, the target variables are measured repeatedly
at baseline and during follow-up, and thus we have intrinsic within-subject correla-
tions. In this case, to reduce measurement errors, researchers take repeated mea-
surements on the same subjects, which may also involve within-subject correlations.
The DataSifter II framework can be applied to any correlated data. For illustration
purposes in this study, we investigate the use of DataSifter II on longitudinal data.
Consider a longitudinal EHR dataset with n patients, each recorded until J thi visit,
where the time intervals between visits are similar across patients. We collect ml
longitudinal variables at each visit and ms static variables for patient characteristics.
For simplicity, we denote time-varying variables as Y ’s and time-invariant variables
as X’s. In the following sections, we use i = 1, ..., n to denote patients; j = 1, ..., Ji to
denote the visit time, which allow different visit times among patients; and k to index
the variables (columns) in the dataset such that for static variable k = 1, ...,ms, and
for longitudinal variable k = 1, ...,ml. Dummy variables are created for all categorical
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with patient i’s, time j’s record of longitudinal variable k denoted as Yi,j,k. The
time-invariant variables of subject i are denoted as Xi = (Xi1, ..., Xims), which can
also be represented as Xi = (Xi1, ...,Xims) to match the dimension of Yi where
Xik = (Xi,1,k, ..., Xi,Ji,k)
T , and k = 1, ...,ms repeats the static variable for Ji times.
Missing data occurs often in longitudinal observations. Missingness can come from
a completely missing record or partially missing record, where patient i does not have
all data available for some visits. In this case, we denote the missing indices for kth
outcome as misk = {(i, j)|Yi,j,k = NA }, and observed indices as obsk = {(i, j)|Yi,j,k 6=
NA}. Fully observed long format data Y(∑i Ji)×(ml) = (Y1, ...,Yn)T has ∑i Ji rows
andml columns. Similarly, the static variables are denoted as X(∑i Ji)×ms = (X1, ...,Xn)T .
We use D = [X,Y] to denote the observed dataset.
While generating partially synthetic data, we view data obfuscation as an artificial
missing creation and imputation procedure. Here we focus on obfuscating time-
varying data and further denote each row in partially synthetic time-varying data
as (Yi,j,nrepij , Ŷi,j,repij), where nrepi,j is a set of indexes for unreplaced variables,
repi,j is a set of indexes for replaced variables compared with the original row such
that nrepi,j ∪ repi,j = {1, ...,ml}, and Ŷi,j,repij is a vector of the synthetic values
created for patient i’s record at time j. Similarly we denote one row in the synthetic
static data as (Xi,nrepi , X̂i,repi), where nrepi and repi are indexes for unreplaced and
replaced variables, and X̂i,repi denotes a vector of synthetic values for patient i’s static
characteristics. Finally, we use Z to denote a synthetic dataset that is composed of
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the time-varying and static synthetic data components.
2.3.1.2 Data Privacy Measurement
In this section, we formally define data privacy in the form of disclosure risk and
compare the disclosure risk between MI and DataSifter methods. Assume we have a
ml-dimensional partially synthetic time-varying data vector yi,j = (yi,j,nrepi,j ,yi,j,repi,j)
corresponding to each individual i at time j in the original dataset D and the static
portion of data is complete. We have a partially synthetic dataset Z that follows a sim-
ilar joint distribution as the original data with unchanged static variables (unobfus-
cated). Specifically, we denote the partially synthetic dataset generated by DataSifter
as Zsift and U (U ≥ 2) multiply imputed (MI) datasets as ZMI = (Z(1)MI , ...,Z
(U)
MI).
To compare the disclosure risk between the sifted and multiply imputed partially
synthetic datasets, we closely follow the Bayesian risk approach described in [60].
Suppose an intruder is interested in learning some the true values in the yi,j vector.
Let A represent the intruder’s prior knowledge about the original dataset D, which
is often referred to a subset of records in D−(i,j) = D \ {yi,j}. Let S denote any
information known by the intruder about the synthetic data generation procedure.
Then, define the disclosure risk for yi,j,k as the conditional distribution
p(Yi,j,k = yi,j,k|Z, A, S)︸ ︷︷ ︸
disclosure risk
,
where j ∈ nrepi,j∪repi,j. The intruder cannot infer the location (indices) of unchanged
(nrepi,j) and changed (repi,j) cells in Zsift, whereas the unchanged cells in a set of U
multiple-imputed datasets would imply the index locations for nrepi,j. Hence, for the
output sifted dataset, we have the disclosure risk:
p(Yi,j,k = yi,j,k|Zsift, A, S).
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For ZMI we have
p(Yi,j,k = yi,j,k|ZMI , A, S) ={1− I(k ∈ nrepi,j)}p(Yi,j,k = yi,j,k|ZMI ,Yi,j,nrepi,j = yi,j,nrepi,j , A, S)
+ I(k ∈ nrepi,j),
where I(k ∈ nrepi,j) is an indicator that takes the value of 1 when the data cell
(i, j, k) of the multiple imputed datasets are not replaced with obfuscated value.
When k ∈ nrepi,j, the intruder knows that ZMI contains true value at cell (i, j, k) so
that the discourse risk is 1. On the other hand, when k /∈ nrepi,j, it is appropriate
to assume that knowing which columns in the record for patient i’s jth visit contains
true values (knowing Yi,j,nrepi,j = yi,j,nrepi,j) yields similar or higher disclosure risk
compared to not knowing the locations as it provides more information about the
true covariates for Yi,j. When the information contained in Zsift and ZMI is similar
regarding to inferring the distribution of Yi,j,k, we have
p(Yi,j,k = yi,j,k|ZMI , A, S) ≥ p(Yi,j,k = yi,j,k|Zsift, A, S).
Therefore, when both synthetic datasets contain comparable information, the DataSifter
output has smaller, or rarely similar, disclosure risk compared to the multiple impu-
tation method.
Data governors can quantify the privacy protection level of the synthetic data
using our disclosure risk defined above. Specifically, when calculating the maximal
privacy loss for each record, we assume the intruder knows all other records in the
raw dataset, i.e. A = D−(i,j), and the imputation model for the synthetic data is
known. The proposed data privacy measurement (PM) for cell (i, j, k) is defined as
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the difference between the expected and observed value:
PMi,j,k =E(Yi,j,k|Z,D−(i,j), S)− yi,j,k
=
{∫
y · p(Yi,j,k = y|Z,D−(i,j), S)dy
}
− yi,j,k.
In practice, the conditional model for Yi,j,k is constructed using D−(i,j) with the identi-
cal model specification as the missing imputation model. For Yi,j,k in Zsift or replaced
cells in ZMI , we calculate the expected difference between the model prediction given
other covariates in the synthetic data and the true value. For ZMI , the privacy
measurement of Yi,j,k for unchanged cells is 0. Assume we introduce a percent of
artificial missingness to the original data and D−(i,j) provides sufficient information
for accurate Yi,j,k predictions. For MI, there are (1 − a) of Yi,j,k with PM = 0 and
the remaining cells have equal or slightly smaller PM. Thus, DataSifter is expected
to improve PM by at least 1/a times compared to MI. We examine the average pri-
vacy measurement for every time-varying variable in the simulation and application
sections below.
2.3.1.3 Data Utility Measurement
Given a pre-specified model, we can obtain the desired utility of the partially
synthetic data by comparing the model fitted with the original and synthetic data in
terms of model inference and/or prediction accuracy. For model inference, the data
governor can consider a feasible parametric model regressing a summary variable on
other covariates. For example, in EHR data, we can predict patients’ comorbidity
score over time, which represents a summary score for the patient’s medical conditions.
To test the data utility based on a regression coefficient β, we first fit the desired
model with the original dataset and obtain its confidence interval. Then, we generate
L partially synthetic datasets under the same target parameter setting, where L is a
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large positive integer. By fitting the desired model on each synthetic data, we obtain
a set of β̂l, l = 1, ..., L and corresponding confidence intervals (LBβ̂l ,UBβ̂l). In the
ideal case, where the true coefficient β∗ is known, we can directly use the confidence
interval coverage, i.e.
∑L
l=1 I{β∗∈(LBβ̂l ,UBβ̂l )}
L
as our utility measurement. In practice,
we obtain the empirical confidence interval for β̂l from the synthetic datasets and
measure if it overlaps with the confidence interval provided by the original dataset.
In terms of prediction accuracy, we can set aside a randomly selected test set and
compare the prediction error between models constructed with the remaining original
and synthetic data records.
2.3.2 DataSifter II Technique
The proposed DataSifter II procedure operates on static variables X and time-
varying variables Y separately and merges the two components back together to form
the final partially synthetic data. The static variables are obfuscated with DataSifter I
algorithm. The DataSifter II requires complete static variables as candidate predictors
while obfuscating Y. We handle possible missingness for time-invariant variables
by missForest technique [80]. When obfuscating Y, we first impute the original
missingness in Y with inverse probability weighted imputation models. Then, we
randomly introduce missingness to the working time-varying data and impute back
with a proposed robust imputation method.
The main assumptions of the DataSifter II include: (A1) the possible missing-
ness in the original data follows missing at random (MAR) or missing completely
at random (MCAR) missing mechanism; (A2) The utility of each variable is equally
important. We consider above assumptions because (A1) guarantees the imputation
accuracy and (A2) allows indistinctive obfuscation for each variable.
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2.3.2.1 Sifting Static Variables with DataSifter I
We apply DataSifter I to obfuscate the static portion X. DataSifter I use miss-
Forest to impute potential missingness in the original data, introduce artificial miss-
ingness to the working data and impute the missing cells back, and swap partial
information for similar records. The resulting sifted data has complete records shar-
ing the same format with the original data.
The imputation procedures in DataSifter aim to create a single complete dataset
disguising the original or artificial missing positions. We use the missForest technique
that outputs a single imputed dataset and is proven to have smaller imputation errors
than common methods including multiple imputation [80, 89]. This non-parametric
imputation technique sequentially imputes and updates the data by variable. In the
first iteration, when imputing for the first target variable, it fills in the missing cells
among other predictor variables with mean imputation. Then, it constructs random
forest models (target variable versus all other variables) to provide imputations. In
subsequent iterations, while imputing and updating by variable, the imputation ac-
curacy for each target variable improves as the missing cells in all other variables are
replaced with better predictions.
When imputing the original missing data, we employ the original stopping cri-
terion in missForest. It stops to iterate when the difference between the latest and
prior imputed data matrix is at least as great as the previous difference measured or
the maximal iteration limit has achieved. The difference between matrices in sets of




























k is the imputed vector and X̂
(r)
ik is the imputed value for subject i of the
kth variable in the rth iteration.
When imputing artificial missingness, the true missing value is known. We define











is the imputed values.
2.3.2.2 Iterative Imputation Algorithm for Time-varying Data
Although DataSifter I applies robust nonparametric imputation methods like miss-
Forest to impute static missing variables, effective missing imputation for time-varying
data can be challenging. In this chapter, we propose an iterative imputation algorithm
for longitudinal data similar to the missForest algorithm. The proposed algorithm
considers two types of missing mechanisms (MAR and MCAR) and two modeling
options (linear mixed model and RE-EMtree). It handles missingness in time-varying
variables Y with complete static variables X as potential predictors.
Before the imputation, we initiate all missing cells with the closest value from the
same subject (last value carry forward or next value carry backward). If the subject
has no observations of certain variables, we initialize such missing cells with mean
imputations. Then, we sort the variables ascendingly based on missing percentage so
that Y·,·,1 has the smallest missing percentage and Y·,·,ml has the most missing. Next,
we start our iterative imputation procedure. Within an iteration, we impute from
the first to the last variable with missing. While imputing a target variable Y·,·,k, we
separate the working data into four groups: the observed values of the target variable
Yobsk,k, variables other than the target among the observed rows [Yobsk,−k,Xobsk,·],
the missing cells of the target variable with current imputation values Ymisk,k, and
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variables other than the target among the missing rows [Ymisk,−k,Xmisk,·], where
obsk and misk are the patient and visit index sets (i, j) with observed and missing
variable k, respectively. Imputation models for the target variable is constructed by
regressing Yobsk,k on [Yobsk,−k,Xobsk,·] and we update Ymisk,k based on the imputation
model. The imputation of a following missing variable k′ (k < k′ ≤ ml) will benefit
from this update because we have better estimates of the missing values in Y·,·,k for
constructing the imputation model or providing covariates when predicting Ymis′k,k′ .
The algorithm finalizes the imputation result of a target variable when the imputation
model predictions for the observed values are close to the true values after multiple
iterations. For artificial missing, we directly compare the true missing values with
its predictions. The algorithm stops when less than two variables are not finalized or
maximal iteration has achieved.
Imputation Model Under Missing at Random Under different missing pat-
terns, the algorithm utilizes different imputation models. When we have MAR, the
missingness depends on observed data and the complete observations might be bi-
ased. We utilize inverse probability weighting to obtain an unbiased pseudo sample
for imputation model fitting. By pseudo sample, we mean the weighted sample that
creates balance by up-weighting the underrepresented population and down-weighting
the over-represented population in the complete observations, where the weights can
be calculated at the subject level, or subject and time level, to allow better imputa-
tion under different situations. For subject level, the probability of missing for each
subject denoted as P{I(Yi contains NA)} is modeled with the corresponding logistic
regression using all working complete static variables and a LASSO penalty is applied




1− P̂ (Yi contains NA)
.
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In observational data like EHR, missingness at the subject and time level happens
sporadically under usual circumstances; i.e., missingness can happen at any time point
for a patient. Similarly, subject i at time j will be weighted by wi,j =
1
1−P̂ (Yi,j is missing)
,
where P̂ (Yi,j is missing) is estimated by a Generalized Linear Mixed Model (GLMM)
and LASSO penalty is applied for variables selection. After estimating the weights for
the observed records, we construct the imputation model for each target longitudinal
variable with a weighted linear mixed model. The linear mixed model with random
intercept follows:
Y·,·,k = X
∗Tβ + ZTb + ε,
where Y·,·,k, k ∈ {1, ...,ml} is the target longitudinal outcome, X∗ are the selected
significant predictors, Z is the design matrix for random effects, bi ∼ N(0, σ2b ), and
εi ∼ N(0, σ2).
Accordingly, Var(Y·,·,k) = σ





the imputation model by optimizing the weighted log likelihood for complete cases:






















i=1 Ji) × (
∑n
i=1 Ji) diagonal matrix. We obtain each stochastic imputation
with X∗i β̂ + b̂i, where b̂i is randomly sampled from N(0, σ̂b
2).
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Imputation Model under Missing Completely at Random Under MCAR, we
propose to employ two modeling options Generalized Linear Mixed Model (GLMM)
[47] or Random Effects-Expectation Maximization tree (RE-EM tree) [77] as impu-
tation models within the iterative procedure. The two procedures are referred to as
DataSifter II GLMM and DataSifter II RE-EM. Note that GLMM can handle var-
ious data types, including continuous, binary, and count data, whereas RE-EM tree
is an effective algorithm for continuous measurements. For the DataSifter II GLMM,
variable selection is conducted separately with GLMM LASSO. Here we perform a
grid search for the regularization parameter and use Bayesian Information Criterion
(BIC) to select the best model. Since an appropriate starting point is crucial for
model convergence, DataSifter II incorporates two methods to initiate the param-
eters when fitting GLMM LASSO. The first method estimates all the parameters
by glmmPQL, which is using pseudo-likelihood. GlmmPQL estimates the mean and
variance parameters iteratively with maximum likelihood assuming normality [95]. It
approximates the true likelihood with a strong normality assumption, but provides a
computationally efficient way of estimating initial regression parameters. When the
signal is sparse, and the GLMM algorithm does not converge with the glmmPQL
initial values, we may consider initialization using zeros or another user-specified
initialization.
Selected variables are denoted as X∗ = (X∗1, ..,X
∗
s), which may come from lon-
gitudinal variables other than the target and static variables. We fit the following
prediction model for every missing longitudinal variable,
ηi,j = g{E(Yi,j)} = X∗Ti,j β + ZTi,jγi,
where g(·) is a known link function, Zi,j is the designed matrix for random effects
γi, γi ∼ N(0, D), i = 1, ..., n represents subjects, and j = 1, ..., Ji are different time
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points.
After estimating β and D using observed data, we impute the missing values by
randomly sampling γ̂i ∼ N(0, D̂) and then obtain a Best Linear Unbiased Prediction
(BLUP) imputation prediction g−1(X∗Ti,j β̂ + Z
T
i,j γ̂i) for Yi,j,k with missing values.
DataSifter II RE-EM provides an alternative robust obfuscation for continuous
time-varying measurements. RE-EM tree model combines the tree-based estimation
for fixed effects and parametric estimation for random effects [77]. RE-EM tree is a
semi-parametric generalization of the linear mixed effect model:
Yi,j = f(Xi,j,1, ..., Xi,j,ms) + Zi,j
Tγi + εi,j,
where (εi,1, ..., εi,Ji)
T ∼ N(0, Ri), γi ∼ N(0, D), f(·) function denotes a regression
tree in the previous model, and Ri records the variance-covariance structure for i
th
error term. RE-EM tree enjoys the capability of modeling the non-linear trend for
fixed effects so that variable selection can be avoided. Parameter estimation for the
RE-EM tree follows a two-step procedure: First, when estimating f(·), RE-EM tree
adapts the CART tree algorithm. Assuming that γ′is are known and equal to the
current estimate γ
(r)
i , the outcome of f(·) is Yi,j − Zi,jTγ
(r)
i . Fitting the tree is a
binary recursive procedure that splits the whole population into similar subgroups.
The default minimum number of subjects in the terminal node is set to 20. Also, a
new split will be made when the reduction in sum of squares between the individual
outcome and group average is less than 1%. In other words, we set the complexity
parameter (cp) to be 0.01. To avoid overfitting, pruning is done by 10-fold cross-
validation after the initial fitting. The final tree is selected with the largest cp value
within one standard error above the minimized 10-fold cross-validated error. Second,
extract the random effect estimates γ̂i from a linear mixed model that regress Yij on
f̂(Xi,j,1, ..., Xi,j,ms).
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2.3.2.3 Create Partially Synthetic Time-varying Data
Using the proposed iterative imputation tool, we can create partially synthetic
time-varying data by handling potential missing in Y, generate artificial missingness
and impute back.
Similar to the preprocessing step for static variables, we intend to initiate the
process with a complete dataset containing both static and time-varying data. The
working complete static data X can be obtained from missForest imputation. If
missing values exist in the time-varying variables, we pre-process the data using the
proposed imputation algorithm under MAR assumption. In practice, we can choose
the subject level or subject and time level propensity model for missing based on
different missing patterns, i.e., we model P{I(Yi contains NA)} if missingness usually
happens at subject level and P{I(Yij = NA)} if missingness happens sporadically.
Since the true missing values are unknown, we finalize the imputation result for a






< ε at current iteration r for a pre-specificed
tolerance level ε, where k ∈ {1, ...,ml}.
Following the initial imputation, we start Sifting by introducing artificial random
missing values to the longitudinal variables in the working complete dataset. Such
randomly generated missingness follows a MCAR missing mechanism, which guar-
antees that the unweighted complete-case analysis is bias-free. We then impute the
missing variables one by one with the proposed imputation procedure under MCAR
with a data driven choice of either the parametric or semi-parametric imputation
model.
2.3.2.4 Implementation of DataSifter II
We use Algorithm 2 to summarize the proposed imputation method for time-










at tolerance level ε. When imputing artificial missing data, the original missing values









Algorithm 2 Time-varying data missing imputation algorithm
1: Input: complete static variables X ∈ R(
∑
i Ji)×ms , time-varying variables Y ∈
R(
∑
i Ji)×(ml), missing mechanism (MAR or MCAR), imputation model (GLMM
or RE-EMtree), and tolerance level ε.
2: Initially impute the missing cells in Y with a combination of last value carry
forward and next value carry backward.
3: Sort the ml variables in Y based on missing rate so that the first variable in Y
has the least missing and the last variable in Y has the most missing.
4: Create a list of missing variable indexes vlist = {km, ...,ml} where missingness
appear from the kthm variable.
5: Sort the ml variables in Y based on missing rate so that the first variable in Y
has the least missing and the last variable in Y has the most missing.
6: Create a list of missing variable indexes vlist = {km, ...,ml} where missingness
appear from the kthm variable.
7: repeat
8: for k ∈ vlist do





11: if missing mechanism = MAR then
12: Construct propensity score model for missingness and calculate the in-
verse probability of missing for records with row indexes obsk.
13: Perform variable selection with LMM with LASSO using Yobsk,k as out-
come and [Yobsk,−k,Xobsk,·] as potential predictors.
14: Fit inverse probability weighted LMM with Yobsk,k as outcome and se-
lected predictors as covariates.
15: Impute missing values Ymisk,k using the weighted LMM.
16: else
17: if imputation model = GLMM then
18: Fit GLMM with LASSO regularization regressing Yobsk,k on
[Yobsk,−k,Xobsk,·].
19: else
20: Fit RE-EMtree regressing Yobsk,k on [Yobsk,−k,Xobsk,·].
21: end if
22: Impute missing values Ymisk,k using the fitted imputation model.
23: end if
24: end for
25: iteration = iteration +1
26: if Imputation finalizing criteria at tolerance level ε has met then
27: Exclude k from vlist.
28: end if
29: until iteration > maxit or the length of vlist ≤ 1.
30: Output sifted time-varying variables Ys.
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We summarize the implementation of DataSifter II with Algorithm 3.
Algorithm 3 DataSifter II
1: Input: static variables X ∈ Rn×ms , time-varying variables Y ∈ R(
∑
i Ji)×(ml),
imputation model I, DataSifter I obfuscation level L, percent of artificial missing
to introduce a, and tolerance level ε.
2: Operate DataSifter I on the static variables under obfuscation level L and obtain
complete static variables. For patient i create Ji replicates of the working complete
static record to create Xs ∈ R
∑
i Ji×ms .
3: Operate Algorithm 1(Xs,Y,MAR,GLMM,ε) to impute possible original miss-
ingness in Y.
4: Introduce random missingness to a% of data values for data obfuscation purpose
among the ml time-varying variables in the working data and obtain data with
artificial missingness denoted as Y∗. Record real values of the missing cells.
5: Operate Algorithm 1(Xs,Y∗,MCAR,I,ε) to obtain sifted time-varying variables
Ys.




The residuals or errors introduced by DataSifter II obfuscated values follow a







< ε, the summation of absolute residuals is




. Thus, the model fitting can be assessed with the observed versus
predicted values diagnostic plot. First, we subset the obfuscated cells. Then, we plot
the observed values in the vertical axis and the predicted values on the horizontal
axis. When the two values are only different by a small error term, the diagnostic
plot shapes like a diagonal line. If the presence of significant outliers is detected,
we may consider alternative strategies to remedy these atypical cases, e.g., removing




In this section, we conduct controlled simulation studies to evaluate the data
privacy and utility protection of DataSifter and multiple imputation methods. The
original simulation data is generated with n = 500, or n = 1, 000 subjects, each with
Ji time points, where Ji varies from 1 to 10 with equal probability, two longitudinal
variables (Y1 and Y2), five static independent true predictors (X1, X2..., X5), and
w = 5 or w = 20 white noise variables. The static true predictors are generated
by normal distributions with different means and unit variance. The white noise
variables are also generated by normal distributions, but with a different set of means
and larger variances. The longitudinal variable Y1 is associated with static variables
only (X1, X2, X3) and Y2 is associated with both static (X4, X5) and longitudinal (Y1)
variables. We consider linear and non-linear associations when generating Y1 and Y2.
Under linear association, Y1 is generated by the following Linear Mixed Model:
Yi,j,1 = 1−X1,i − 0.5X2,i − 0.3X3,i + 0.8V isiti,j + b0i + εi,j,
where i = 1, ..., n is the indicator for patients, and j = 1, .., Ji is the indicator for
time. Here Ji is the total visit number for patient i and Ji ∈ {1, 2, ..., 10}, b0i is
a subject specific random intercept that follows a N(0, 1) distribution, and εi,j are
independent for different time points and follows N(0, 4). Variable Y2 depends on two
static variables and Y1.
Yi,j,2 = −15 + 0.2Yi,j,1 −X4,i + 0.2X5,i + 2V isiti,j + b1i + εi,j.
Similarly b1i ∼ N(0, 1) and εi,j ∼ N(0, 4). We know that under random intercept
V (Yi,·,1) = ZiDZ
T
i + σ
2IJi where Zi = 1Ji×1, D = V ar(b0i) and σ
2 = V ar(εi.j).
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. After some calculations, Corr(Yi,j,1, Yi,j′,1) = 0.2 for all i and j 6= j′.
Similarly, Corr(Yi,j,2, Yi,j′,2) = 0.2.
We also consider cases with non-linear relationships. Similar to the linear set-
ting, we construct models with compound symmetry correlation structure. Our two
longitudinal variables are derived by:
Yi,j,1 = 10 + 3 sin(X1,i)− 0.2X22,i − 0.1X1,i · |X3,i|+ V isiti,j + b′0i + ε′i,j,
and
Yi,j,2 = 2 + 0.05 sin(Yi,j,1) + 0.4 exp{cos(X4,i)}− 0.02Yi,j,1 · |X5,i|+ 2V isiti,j + b′1,i + ε′i,j,
where b′0i ∼ N(0, 9), b′1i ∼ N(0, 16), and ε′i,j ∼ N(0, 64). We have V ar(Yi,j,1) =
73, Corr(Yi,j,1, Yi,j′,1) = 0.12, V ar(Yi,j,2) = 80, and Corr(Yi,j,2, Yi,j′,2) = 0.2, where
j 6= j′.
The complete data generated by the above procedure will be used to examine
different data obfuscation methods. To mimic real-world data, we also consider a
scenario where some observations in Y1 and Y2 contains missing values, which follow
the MAR missing data mechanism. First we define the missing indicator for variable
Y1 to be M(Yi,j,1) = I(Yi,j,1 = NA), ∀i ∈ {1, ..., n} and j ∈ {1, ..., Ji} and similarly
for Y2. The original missingness M(Yi,j,1) and M(Yi,j,2) is generated from the two sets
of logistic regressions. The first set considers different probabilities of missingness at
individual and time level. Under this model, we allow partially missing subjects.
logit[P{M(Yi,j,1) = 1}] = −2 + 10X1,i − 10V isiti,j + bi.




i ∼ N(0, 1). The two models will provide around 20-30% missingness for
each longitudinal variable.
We compare the performance of four types of synthetic datasets: DataSifter with
GLMM generated on complete original data, DataSifter with RE-EM tree gener-
ated on complete original data, multiple imputed synthetic data generated on com-
plete original data, and DataSifter with RE-EM tree generated on original data that
contains missing. All the sifted data are generated without static data obfuscation
(L =no obfuscation). We applied the multiple imputation method using two-level
normal models with homogeneous within group variances as the imputation model to
create multiply imputed partially synthetic datasets, which is implemented in mice
R package [74, 6]. We compare the first three types of synthetic data to assess the
obfuscation performance. To demonstrate that DataSifter can successfully handle
missingness in the original data, we further show that the decrease in data utility
preservation is small after bring in original missingness under the RE-EM tree im-
putation method. All synthetic data are generated by randomly introducing 20%
artificial missingness in Y1 and Y2 and impute the missing cells back. Static variables
including the white noise variables are not obfuscated. One hundred replications are
constructed for each type of synthetic datasets under every simulation setting.
2.3.3.2 Simulation Results
Using the proposed data utility and data privacy measurement, we evaluate syn-
thetic datasets generated by DataSifter and MI. Data utility is measured in terms of
prediction accuracy and inference based on models trained on synthetic datasets. For
prediction accuracy, we construct test sets with identical sample size as the training
dataset (n = 500 or n = 1, 000 and Ji ∈ {1, ..., 10}). We then use the predictive
models constructed on the synthetic datasets to predict the target longitudinal vari-
ables in the test set. Absolute deviance in predicted and observed values of Y1 and
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Y2 are calculated as the prediction error. Model inference is measured by the 95%
confidence interval coverage of the true parameter value among the 100 replications
under linear association scenario. Data utility is examined using the average privacy
measurement (PM) for the first 100 records of Y1 and Y2. As defined in section
2.3.1.2, for an obfuscated (replaced) target cell Yi,j,k, we use the conditional model
fitted by D−(i,j) to represent intruder’s prior knowledge and PMi,j,k is the difference
between the conditional mean and the observed yi,j,k.
The average prediction errors on test data are summarized in Table 2.2. Based
on 100 replications, under most simulation settings, the average test error on Y1 and
Y2 are similar across different synthetic data generation methods and these results
are indistinguishable from the original data. For Y2 under linear association, the MI
method provides a slightly better prediction results of less than 15% improvement.
This indicates the parameter estimations with synthetic data generated by DataSifter
are relatively accurate. Note that whether or not we have missingness in the original
datasets, the DataSifter RE-EM tree provides similarly accurate coefficient estimates.
Moreover, stable results are observed under both linear and nonlinear associations,
training sample sizes and noise levels, which suggests that our proposed imputation
method is robust.
Since the proposed imputation method is aimed at minimizing imputation error
rather than accounting for uncertainty of the missing values, the 95% confidence
interval constructed on sifted datasets are narrower than the original data. As shown
in Table 2.3, for variable Y1, the MI method achieves desired 95% coverage while the
DataSifter GLMM achieves 89-98% accuracy. Due to the slower convergence rate of
non-parametric estimations and non-linear model specification, the synthetic datasets
generated by DataSifter RE-EM have smaller CI coverage ranging from 76-94%. For
Y2 , the CI coverage for X4 (one of the static predictors) is relatively small under the
DataSifter methods (43- 68%). Nevertheless, we observe that the DataSifter GLMM
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Original 1.858 1.858 20.471 20.471 1.903 1.903 7.649 7.649
Multiple Imputation 1.851 1.867 20.295 20.289 1.903 1.922 7.693 7.818
DataSifter GLMM 1.903 1.901 20.538 20.525 2.151 2.144 7.949 7.949
DataSifter RE-EM 1.896 1.896 20.503 20.516 2.153 2.149 7.705 7.710
DataSifter RE-EM
with original missing
1.871 1.873 20.121 20.101 2.184 2.205 7.728 7.730




















Original 1.870 1.870 20.746 20.746 1.861 1.861 7.410 7.410
Multiple Imputation 1.863 1.883 20.563 20.596 1.863 1.891 7.420 7.520
DataSifter GLMM 1.911 1.911 20.817 20.801 2.100 2.111 7.738 7.741
DataSifter RE-EM 1.911 1.914 20.806 20.797 2.109 2.122 7.456 7.459
DataSifter RE-EM
with original missing
1.864 1.864 19.985 19.998 2.245 2.248 7.729 7.732
Table 2.2: Mean absolute deviation (prediction error) for test dataset based on model
fitted on original and synthetic datasets. The test datasets are generated separately
with the same sample size as the training sets.
method (87% and 84%) provide a much better CI coverage for predictor Y1 compared
to the MI method (39% and 21%). This is because the proposed iterative imputation
method updates the missing predictor information during each iteration while MI is
solely based on complete data. The CI coverage based on the DataSifter RE-EM
tree method is smaller when the original data contains missing values. However, the
reduction in CI coverage is alleviated for a larger sample size.
The average privacy measurement for different synthetic datasets is illustrated in
Figure 2.7. Each boxplot records the distribution of average privacy measurement
for Y1 and Y2 over 100 replications among the first 100 records. Under all scenarios,
the two DataSifter methods have similar privacy measurement values and distribu-
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Covariate X1 X2 X3 X1 X2 X3 X4 X5 Y1 X4 X5 Y1
Original 0.940 0.950 0.960 0.940 0.950 0.960 0.970 1.000 0.960 0.970 1.000 0.960
Multiple Imputation 0.940 0.970 0.950 1.000 1.000 1.000 0.960 1.000 0.860 0.980 1.000 0.390
DataSifter GLMM 0.900 0.920 0.930 0.940 0.950 0.930 0.680 0.930 0.890 0.590 0.940 0.870
DataSifter RE-EM 0.870 0.860 0.870 0.900 0.940 0.860 0.670 0.850 0.740 0.600 0.850 0.720
DataSifter RE-EM
with original missing
0.690 0.850 0.690 0.660 0.840 0.700 0.490 0.840 0.760 0.440 0.880 0.730












Covariate X1 X2 X3 X1 X2 X3 X4 X5 Y1 X4 X5 Y1
Original 0.950 0.960 0.960 0.950 0.960 0.960 0.960 0.970 0.880 0.960 0.970 0.880
Multiple Imputation 0.960 0.980 0.960 0.990 1.000 1.000 0.960 0.940 0.660 0.990 0.990 0.210
DataSifter GLMM 0.930 0.960 0.960 0.890 0.980 0.960 0.430 0.860 0.790 0.440 0.910 0.840
DataSifter RE-EM 0.930 0.890 0.760 0.880 0.940 0.770 0.440 0.730 0.510 0.430 0.740 0.550
DataSifter RE-EM
with original missing
0.730 0.850 0.760 0.730 0.840 0.770 0.260 0.870 0.520 0.270 0.840 0.530
Table 2.3: Confidence interval (95%) coverage based on 100 replicates under different
models. The coverage records the percent of times that CIs from models trained on
original and synthetic datasets cover the true parameter estimate.
tions. The MI method offers significantly lower privacy measurement, see Figure 2.7.
In fact, when introducing 20% artificial missingness to the longitudinal variables, the
average mean privacy measurement is around 5.25 times higher in sifted datasets com-
pared to multiply imputed datasets. This result provides empirical evidence for the
privacy measurement (PM) improvement derivation, see Section 2.3.1.2. Compared
to multiple imputed datasets, sifted datasets have at least 1/a times higher average
PM, where a is the percent of the introduced artificial missing values in the data.
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Figure 2.7: Average privacy measurement among first 100 rows in the synthetic
datasets. The scenario with small noise level contains w = 5 and large noise level
contains w = 20 white noise variables.
2.3.4 Clinical Data Application using MIMIC-III
The Medical Information Mart for Intensive Care III (MIMIC-III) represents a
sizable single-center database that provides patients’ medical records in a large ter-
tiary care hospital between 2001 and 2012. MIMIC-III data stores information related
to patients’ admission, including vital signs, medications, laboratory measurements,
length of stay, survival data, and more [34]. We consider a subset of 7,080 patients
who had at least two visits to the hospital who contributed 17,594 hospital admission
records with demographic variables, including insurance type, gender, race, age, mar-
ital status, and death after admission. Admission information such as insurance type,
admission type, and month of admission is also available. MIMIC-III contains de-
identified or coded data that is considered not involving protected health information.
However, the data request process including taking an online course and submitting
an application with specific research topics and requested information can still take
more than three weeks. Using the data for any rigorous scientific investigation re-
quires the researcher to go through a time consuming data request procedure, while
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at the end the investigation may find no significant results. DataSifter II allows a
quicker turnaround for checking the potentials of research hypotheses. For example,
we want to investigate the association between length of stay in tertiary care hospitals
and Medicaid insurance type controlling other patient demographic variables using
the MIMIC-III data. We illustrate how to use the sifted data to answer our initial
research question, and evaluate both utility and privacy protection performance in
the sifted MIMIC-III data. We also compare the synthetic MIMIC-III datasets gen-
erated by DataSifter II with that of the multiple imputation method. A linear mixed
effect model is used to regress the length of hospital stay on patient characteristics.
The privacy protection effort is measured by the privacy measurement (PM) for age
and length of hospital stay among the first 100 records.
First, we obfuscate the following longitudinal variables: (1) length of stay, (2)
month of admission, (3) death after visit, (4) age at visit. We consider generating
two types of Siftered data: with (L =medium) or without (L =no obfuscation) static
data obfuscation using DataSifter I. By using the DataSifter II protocol, we introduce
20% missingness in the longitudinal variables specified above to obtain the first type
of sifted data without static obfuscation. The RE-EM tree model is used as the
imputation model because of its more flexible mean structure. Then, we generate
the second type of sifted data with further obfuscation on the static variables using
DataSifter I under the medium level of obfuscation, which entails two rounds of
artificial missing introduction and imputation, each one randomly obfuscating 25%
of the cells. The other setting for the medium obfuscation level defines neighbors
as the cases with the closest top 5% distance and swap 60% of the features with
a neighboring case. As a comparison, we also create partially synthetic data with
multiple imputation (MI) based on 20% random artificial missingness on the four
longitudinal variables. In each replication, the MI dataset and the Siftered dataset
without static obfuscation have the same amount of data cells being replaced. The
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Sifterd dataset with static obfuscation has the highest level of privacy protection
among the three by altering an extra 25% of the cells in the static data. Fifty
replications are generated for each type of partially synthetic data.
Next we compare the model parameter estimates between models fitted on the
original data and on the three different types of synthetic data, assuming the following
linear mixed effect model:
Length of stayi,j =β0 + β1Age + β2Medicaid + β3Private insurance + β4White + β5Black
+ β6Male + β7Emergency admission + β8Urgent admission
+ β9Single + β10English language
+ β11Visiti,j + b1iVisiti,j + εi,j,
where b1i ∼ N(0, σ2b1), and εi,j ∼ N(0, σ2).
Results in Figure 2.8 show that the DataSifter II provides much better privacy
protection than the MI method with a small loss in data utility. Medicaid is not
associated with the length of stay in any synthetic and original data fitted models.
According to Figure 2.8 A, most of the mean PM by row (record) are below five
among the 50 multiply imputed synthetic datasets. The average PM is 0.33 for age
at admission and 1.53 for length of hospital stay. The DataSifter method provides a
significant improvement in terms of PM with 14.87 and 8.17 as the average PMs for
age and hospital stay, respectively. We can also infer from Figure 2.8 A that the
mean PMs can vary considerably from row to row in sifted datasets without static
obfuscation.
Figure 2.8 (B) illustrates the deviance of parameter estimates between the model
fitted with three types of synthetic dataset and the original linear mixed model. Only
significant parameter estimates are shown in the plot. The box plots represent the
empirical confidence intervals (CIs) or the distribution of β̂’s among 50 replicates.
The black dots and purple intervals illustrate the coefficient estimates and CIs from
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the original model. According to Figure 2.8 B, all the empirical CIs from MI and
DataSifter without static obfuscation overlap with the CIs acquired from original
data. The MI created synthetic datasets provide the most accurate β̂’s that align
closely with the original estimates and a small estimation bias is observed for the
sifted data without static obfuscation. Five out of seven empirical CIs from the
model constructed from the sifted data with static obfuscation have overlapped with
the original CIs. The results suggest that the data utility is well preserved in sifted
datasets after intensive obfuscation.
Variable: Length of Stay
Variable: Age at Admission
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Figure 2.8: MIMIC III synthetic data privacy (A) and utility (B) evaluation. Plot
A summaries the distribution of mean privacy measurement for age and length of
hospital stay for first 100 rows across 50 synthetic datasets generated by DataSifter
(without static obfuscation using DataSifter I) and multiple imputation. Plot B
compares the significant coefficient estimates (p-value < 0.05) among the models
fitted with original data, and synthetic datasets generated by DataSifter II (with
or without static obfuscation) and multiple imputation. The boxes illustrate the
distribution of coefficients estimated on 50 synthetic datasets. The black dots and
purple intervals are the parameter estimates and confidence intervals from the linear
mixed model fitted by the original dataset.
Since none of the fitted models obtained from the sifted datasets shows significance
of the effect β2, researchers who are interested in the relationship between Medicaid
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and length of hospital stay may conclude ”no statistical association” from any one of
the sifted datasets presented in the simulation study.
2.4 Discussion
The results shown above illustrate that the DataSifter technique balances be-
tween maintaining the energy of the original data (preserves information utility)
while simultaneously introducing a level of privacy protection safeguarding against
re-identification of sensitive information contained in the archive.
According to the reported simulation studies, under a careful set-up for user-
defined privacy levels, DataSifter I can successfully provide privacy protection while
maintaining data utility. The clear negative relationship between the level of obfus-
cation and the proportion of PIFVs indicates that a high user-specified privacy level
does provide increased privacy protection for sensitive information. Using DataSifter
under “large” or “indep” settings, patient privacy was highly protected. Data re-
identification was almost impossible by stratification filtering of the targeted patients
via known feature values. This is due to the method’s inability to distinguish be-
tween real, imputed, or obfuscated values within each real feature, and the relatively
small proportion of untouched data elements. Of course, caution needs to be exer-
cised, as multiple queries resulting in repeated “sifted” data instances may expose the
overlapping “true” values especially for low levels of obfuscation. However, the large
proportion of “sifted” elements protects sensitive information and may allow data
users to request a small number of data queries. The application of DataSifter I on
ABIDE provided a realistic demonstration of how to employ the proposed algorithm
on EHR. Also, the application confirmed DataSifter I’s ability to handle high di-
mensional data. The excellent prediction performances on the “medium” obfuscation
level suggested similar data utility between original and “sifted” data.
For DataSifter II, The simulation results based on introducing 20% artificial
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missingeness suggest that data utility is better preserved for longitudinal variables
that depend only on static variables (Y1) compared to variables that depend on both
static and longitudinal variables (Y2). The two imputation method options, GLMM
and RE-EM tree, provide accurate and computationally efficient imputations for Y1
and Y2 under the both linear and nonlinear generative models. The RE-EM tree
method is efficient computationally when the number of longitudinal variables is
large, and the number of subjects is small compared to the number of variables in
the data.
Compared to the multiple imputation method, DataSifter II provides extended
privacy protection with moderate utility loss in terms of CI coverage. We showed
that the synthetic datasets generated by DataSifter are more powerful for predictive
model constructions rather than inferential tasks by design to seek for the smallest
imputation error in each obfuscated cell.
We examined the privacy protections of the longitudinal synthetic data propor-
tion using a proposed privacy measurement. The original DataSifter I method can
further ensure that partial information in the time-invariant cross-sectional data is
obfuscated for any non-isolated subject and our application shows that this extra level
of protection only introduces a small bias in model-based statistical inference. When
complete obfuscation for all data elements is required, we recommend the generation
of fully synthetic longitudinally sifted datasets. This new option is implemented in
the DataSifter II R package. It is specified by the setting of level-of-obfuscation pa-
rameter, which is also available in the DataSifter I technique. We define a local value
range (ai,j, bi,j) for each longitudinal variable, individual i, time j, and as the closest-
neighborhood N of nearby observations. Then, we randomly sample with a uniform
distribution bounded by ai,j and bi,j to generate each data point. The fully synthetic
version of DataSifter II introduces errors that are locally bounded. However, it does
not guarantee preservation of within-subject correlations.
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The experimental results show that the sifted datasets preserve the information
content of the original data (utility preservation) at the same time they provide pow-
erful data privacy protections. Depending on the specific data characteristics, the
DataSifter II performance may be impacted in terms of its efficiency and balance be-
tween privacy-protection and utility-reservation. We employed linear (GLMM) model
and tree (RE-EM tree) structure to approximate the distribution for each longitudi-
nal variable conditional on other variables in the data. The utility preservation for
each longitudinal variable may be affected by (1) the complexity of the relationship,
(2) empirical variance of the target time-varying variable, (3) the data type of the
predictors, and (4) alternative within-subject covariance structures.
The DataSifter algorithm provides data governors and researchers with a semi-
automated and reliable framework for sensible information exchange. Despite per-
turbing individual level records, the overall sifted time-varying data shares similar
population level information with the original process. DataSifting allows owners of
data, business managers, biomedical scientists, and clinical researchers to create and
study pseudo populations by sharing obfuscated data objects, instead of the original
sensitive information, and conducting studies on these sifted datasets. This infor-
mation exchange process promotes rapid and effective testing of a priori research
hypotheses (confirmatory analytics), as well as, data-driven discovery science and
formulation of novel translational science questions (exploratory analytics). Many
biomedical areas, clinical settings, and research and development partnerships may
benefit from the DataSifter technology to conduct advanced trans-disciplinary re-
search and translate basic science advances into clinical practice.
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CHAPTER III
Robust Estimation for Viable Optimal DTRs with
Restricted Arms Using Observational Data
3.1 Introduction
Personalized medicine (PM) or precision medicine is an increasingly popular area
of study including a broad range of approaches, which provide individualized solutions
for drug therapy or preventive care. PM is an important research topic since signifi-
cantly different treatment effects of certain medical procedures can be observed from
patient to patient. To make single-stage treatment recommendations, traditional PM
approaches cluster patients into groups based on their cross-sectional demographics
or genetic information. Dynamic treatment regime (DTR) is an effective vehicle for
personalized medicine under the time-varying treatment settings of chronic condi-
tions like drug abuse, cancer, and diabetes, where adaptive treatments are necessary
for patients at multiple stages [10]. To make effective treatment decisions at each
stage, DTR uses patients’ past medical history and current disease status to offer the
most informed individualized treatment recommendation for chronic diseases. Nev-
ertheless, making sequential decisions can be challenging due to the intricate causal
relationships between a sequence of treatments and the final clinical outcome.
Various methods have been developed for estimating optimal DTRs. Marginal
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structural models with inverse probability weighting (IPW) [51, 90], Q- and A-
learning methods [93, 82, 50, 76], and dynamical system models [61] stand out as
the most commonly used parametric methods for estimating optimal DTR. These
methods are highly interpretable but rely heavily on parametric assumptions, which
however could be violated in some scenarios. For example, we may have too many
covariates or limited information to specify reasonable parametric models. Over the
past few years, nonparametric approaches have been proposed to allow more flexi-
bilities and relax assumption restrictions. Among such non-parametric approaches,
tree-based methods not only relax the linear model assumption but also facilitate
the easy interpretability for physicians to understand and use in practice. Laber and
Zhao (2015) [39] employed an inverse probability weighted purity measure to build
decision trees for optimizing the potential health outcomes for a single stage, where
the patient individual medical history are used to tailor the treatment as potential
tree nodes. Tao and Wang (2018) [85] generalized the method to a doubly robust ap-
proach, which provides more robustness using observational data and can also handle
multi-stage treatment situations. Cut-off based verdicts in the tree structure can
provide clear guidance to future clinical practices.
When answering the inferential questions in DTR researches, pre-designed Se-
quential Multiple Assignment Randomized Trials (SMART) are ideal to meet the
desirable casual assumptions. Although SMART were a growing data source for com-
paring or constructing DTR, it is still not easy to perform and implement SMART
in practice since such trials can be expensive and time-consuming. As we enter the
big data era, massive amounts of health records are available for scientific discoveries
and observational studies have their own merits and values for evaluating the optimal
DTRs. There has been a large literature to develop statistical methods for DTR
in observational studies [39, 84, 85]. However, a natural challenge arises since some
observed treatment routes with good-targeted outcomes can be inapplicable or not
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recommended for future patients. Possible sources of the inapplicable routes include
drug recalls and inconsistent treatment applications from different physicians. For
example, it is not meaningful to construct a DTR that contains recalled drugs in a
certain stage or has a weaker medicine following a more aggressive treatment. Al-
though there is a vast literature for estimating optimal DTR, directly applying the
existing DTR methods to data with inapplicable treatment routes can lead to unre-
alistic recommendations for some patients. On the other hand, simply deleting the
patient records with restricted arms is not a solution either since that may induce
selection bias and interpretable DTR is not guaranteed. Therefore, a growing number
of researchers and clinicians are calling for new methods that solve such constrained
optimization problem in observational studies.
In this chapter, we develop the Restricted Tree-based Reinforcement Learning
(RT-RL) method to accommodate restrictions in observational studies by truncating
possible treatment options based on patient history in a multi-stage multi-treatment
setting. The proposed method provides robust and interpretable estimations by em-
ploying doubly robust augmented inverse probability weighted estimators in a tree-
based algorithm. Our algorithm provides optimal treatment recommendations for
patients regarding only applicable treatment options and utilizes all valid observa-
tions in the dataset to avoid selection bias and improve efficiency.
The rest of the paper is organized as follows: In section 3.2 we formulize the re-
stricted optimization problem and our proposed solution by specifying the truncation
process for the patient history and treatment options and describing the Restricted
T-RL estimating procedure. In section 3.3, using simulation studies, we demonstrate
the interpretability, effectiveness, and robust performances of our method by compar-
ing RT-RL with the naive method that deletes all the information in the restricted
arms. In section 3.4, we apply the algorithm to Global Appraisal for Individual Needs
(GAIN) to estimate interpretable two-stage DTR to guide the level of care placement
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for adolescents with substance use disorder. The performance of our proposed method
is compared with the native T-RL and non-dynamic regimes. Finally, in section 3.5
we summarize and discuss the findings.
3.2 Method
3.2.1 Notations and Setup
We consider an observational study with n patients and T treatment stages where
there are Kj (Kj ≥ 2) potential treatment options at the jth treatment stage, j =
1, ..., T . Patients are observed to follow one of the treatments available at each stage.
For brevity, we suppress the patient index i (i = 1, .., n) when no confusion exists.
Let Aj denote the treatment at the j
th treatment stage, where Aj may take a value
aj, a specific value for the j
th treatment assignment that belongs to the stage specific
treatment space Aj = {1, ..., Kj}. Let AT ≡ (A1, . . . , AT ) with a bar “-” denote the
T-stage sequence of treatment indicators. Similarly, we denote the observed treatment
routes with aT ≡ (a1, . . . , aT ). As a general notation in the following, we use a bar
“-” and a subscript j on a variable to denote the history of this variable up to the
jth stage. For example, Aj−1 ≡ (A1, . . . , Aj−1) to denote the past treatments prior
to stage j. Let Rj denote the clinical outcome observed following Aj, also known
as rewards, which depends on the precedent patient characteristics Xj and previous
treatments Aj−1. We consider the overall outcome of interest as some functional
of the reward history such that Y ≡ f(R1, ..., RT ), where f(.) is a pre-specified
function (e.g., sum), assuming Y is bounded and preferable with larger values. To
recommend personalized optimal treatment for future patients at stage j, we infer
from the observed Y, the current candidate treatments aj ∈ Aj and the patient




However, some of the observed treatment sequences are not applicable for future
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patients due to clinical or practical reasons. We define such treatment routes as
restricted treatment arms, which should be excluded from the domain of the DTRs
of interest during estimation. Suppose there are Mj restricted arms at stage j, and
denote them as bm,j = (b1,m,j, ..., bj,m,j) where m = 1, ...,Mj and bj′,m,j ∈ Aj′ for
j′ = 1, ..., j. Excluding restricted treatment arms from the observed treatment stages,
we obtain a set of viable treatment sequences from stage 1 to stage j denoted as
Aresj ≡ Aj/{bm,j,m = 1, ...,Mj}. Correspondingly, the domain of viable patient
history is Hresj = {hj : aj−1 ∈ A
res
j−1}. In the rest of the paper, we denote the random
variable of viable treatment history as Hresj , and the value of H
res
j is in Hresj .
We use gres = (gres1 , ..., g
res
T ) to denote a sequence of restricted viable rules for
personalized treatment decisions across the different treatment stages (total T stages),
i.e., a viable restricted dynamic treatment regime (DTR), where gresj is a meaningful
mapping function from the domain of restricted patient history Hresj to the range of
viable treatment options at j given the past (Aresj ). Denote the collection of such
restricted meaningful mappings as Gres = (Gres1 , ...,GresT ). Specifically, gresj ∈ Gresj
maps from viable treatment histories to applicable stage j treatments conditional on




j )) ∈ A
res
j .
To identify the optimal restricted DTR among Gres, we consider the counter-
factual framework for causal inference defined in Robins, 1986. At stage T, let
Y ∗(A1, ..., AT−1, a
T ) or Y ∗(aT ) denote the counterfactual outcome for patients re-
ceived treatment aT conditional on previous treatments. Our goal is to find the












Y ∗(aT )I{gresT (HresT ) = aT}
]
.
For any stage j before T , we seek the best regime by maximizing the expected coun-
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terfactual outcome with all future treatments optimized to avoid confounding. We
denote the counterfactual outcome at stage j given Aj−1 and future optimal treat-
ments gres, optj+1 , . . . , g
res, opt
T as Y
∗ (Aj−1, aj, gres, optj+1 , . . . , gres, optT ). Since such counter-
factual outcomes cannot be observed, we estimate the stage-wise pseudo-outcome






A1, . . . , Aj, g
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at stage j for j = 1, ..., T −1, where Eres denotes the expectation considering only the
viable patient history and treatment routes space, gres,optj ∈ Gresj and (A1, ..., Aj) ∈




∣∣Aj+1 = gres,optj+1 (Hresj+1) ,Hresj+1} .
At the final stage, POresT = Y . Let PO
res,∗
j (Aj−1, aj), or PO
res,∗
j (aj) for brevity, denote
the counterfactual pseudo-outcome for a patient treated with aj ∈ Aj and viable past








POres,∗j (aj)I{gresj (Hresj ) = aj}.







3.2.2 Constrained Optimization Procedure
To connect the counterfactual outcomes and counterfactual pseudo-outcomes with
observed data, we make the following three assumptions considering only the appli-
cable treatment routes [51, 66, 53]:
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(1) Consistency. If the patient were given the treatments accordingly, the ob-




Y ∗(aT )I(AT = aT ) for stage T , where AT ∈ AresT . Similarly, the es-
timated pseudo outcome agrees with the counterfactual pseudo-outcome POresj =∑Kj
aj=1
POres,∗j (aj)I{Aj = aj} for stage j < T and Aj ∈ Aresj .
(2) No unmeasured confounding. For any treatment sequence aT = (a1, .., aT ),
treatment Aj is independent of future outcomes (rewards), given H
res
j a random
variable that takes value in Hresj , i.e.,
Aj⊥(Rj(aj), ..., RT (aT ))|Hresj , ∀j = 1, ..., T.




j ) = Pr(Aj = aj|Hresj ) ∈ (c0, c1).
With the three assumptions, we can bridge the pseudo outcome estimated from the
observational data with the expected counterfactual pseudo outcome for a specific
regime gresj ∈ Gresj at any stage j < T . Conditional on Hresj , we have
E{POres,∗j (gresj )} = EHresj
 Kj∑
aj=1
E{POres,∗j (aj)|Hresj }I{gresj (Hresj ) = aj}
 .
With no unmeasured confounder assumption, it is easy to show that
E{POres,∗j (gresj )} = EHresj
 Kj∑
aj=1
E{POres,∗j (aj)|Aj = aj,Hresj }I{gresj (Hresj ) = aj}
 .
Then, using consistency assumption and positivity assumption, we can link the coun-
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terfactual with the estimated pseudo outcome
E{POres,∗j (gresj )} = EHresj
 Kj∑
aj=1




j ) = E(PO
res








j )I{gresj (Hresj ) = aj}
 ,














T ) = E(Y |AT = aT ,HresT ).
The proposed method RT-RL utilizes the backward induction technique [4] to
estimate the restricted DTR. The counterfactual mean outcome is estimated by AIPW
estimator similar to [84]. We have modified the estimation of E{Y ∗(aT )} under the
viable patient history spaceHresT at final stage T . Assume we have observed n patients
with nres,T patients received applicable treatment combinations until stage T . We




















Proposition 1 (Double Robustness). Assume patient observations {Xi,Ai,(T−1), Ai,T , Yi}ni=1
are independent and identically distributed that follows certain multivariate distribu-
tion p. A subset of nres,T patients has viable past treatment routes until stage T . We
define viable patient observations as {HresiT , AiT , Yi}n
res,T
i=1 ≡ {Xi,Ai,(T−1), AiT , Yi}n
res,T
i=1





(HresT )} is a consistent estimator of
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E{Y ∗(aT )} if either the propensity score model π̂T,aT (HresT ) or the conditional mean
model µ̂resT,aT (H
res
T ) is correctly specified.




















































the conditional mean model. Similarly, for stage j (1 ≤ j < T ), our proposed estima-


































given the propensity score model π̂j,Aj(H
res




We utilize tree-based reinforcement learning (T-RL) to search for optimal treat-
ment regime that closely follows the procedure proposed by [85], but only con-
sidering the viable restricted space. We propose to utilize the AIPW estimator
Pnres,j{µ̂res,AIPWj,aj (H
res
j )} to estimate E{Y ∗(aT )} or E{PO
res,∗
j (aj)} that serves as the
purity measure for tree model construction at stage T or j < T , respectively. The tree
model divides patients into subgroups with alike histories and recommend the cor-
responding optimal treatment to each subgroup that maximizes the estimated group
average stage-wise pseudo outcome. The proposed procedure provides viable indi-
vidualized treatment solutions tailored by patient characteristics recorded in Hresj .
While considering a partition over node Ω that split patients into two groups ω and
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ωc, we define the purity measure before the partition as:




















× I(Hresj ∈ Ω)
]
,
for j = 1, ..., T , where POresT = Y for final stage. We compare Pj(Ω, φ) with the
purity measure after the partition






















j ) = aj}I(Hresj ∈ Ω)
]
,
where gresj,ω,a1,a2 is the treatment rule that assigns a1 to patient subgroup ω and assigns
a2 to patient subgroup ω
c . We chose the best split ω based on largest improvement
in purity measure Pj(Ω, ω)− Pj(Ω, φ).
3.2.3 Implementing Restricted T-RL
We implement the Restricted T-RL by restricting and allocating patients based
on past treatment sequences during the optimization procedure. This implies that
only patients with viable treatment combination up to stage j, i.e. Aj ∈ A
res
j , can
contribute to the treatment regime estimation at current stage j for j = 1, ..., T .
Among patients with viable treatment sequences up to stage j, we fit separate T-RL
models based on past treatment sequence for patients with (Aj−1, aj) /∈ A
res
j ,∃aj ∈
Aresj who are at risk of receiving inapplicable arms. In each model, we search the best
treatment among {aj ∈ Aresj : (Aj, aj) ∈ A
res
j }. An additional T-RL is fitted using
the remaining patient records with Aj−1 ∈ A
res
j−1, and (Aj−1, aj) ∈ A
res
j ,∀aj ∈ Aresj
without restrictions on candidate optimal treatments.
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Moreover, when the observed treatments of a patient satisfy Aj ∈ A
res
j and Aj∗ /∈
Aresj∗ ,∀j∗ > j with j < T , this patient can only contribute to the optimal regime
estimation for the first j stages. For this patient, since the observed outcome Y is
not informative, POresj is estimated using data from similar patients with applicable
treatments until the j + 1 stage. Prior to stage j, we can use backward induction to
estimate the stage-wise pseudo outcomes.
When fitting tree models, we adapt the stopping criteria proposed by [85] that
considers classic tree-based method pruning parameters to avoid overfitting. Node
size (n0) controls the minimal number of subjects in each final node, and the depth
of the tree (d) avoids complicated regimes. Moreover, a positive constant λ for
minimal purity improvement is used for examining if the current best split ω̂opt =
argmaxω[Pj (Ω, ω)] satisfies Pj (Ω, ω)-Pj (Ω, φ) > λ, which guarantees user-specified
meaningful splits. We set values for n0 , d and λ for pruning based on specific appli-
cations.
For demonstration purposes, from now on, we consider a two stage problem (T =
2) where we have M inapplicable treatment routes bm = (b1,m, b2,m),m = 1, ...,M .
Under this setting, we assume all observed first stage treatments are viable and a2 =
b2,m given a1 = b1,m are not viable for m = 1, ...,M .
In stage 2, we estimate the restricted treatment rule by allocating patients based
on if A1 agrees with any restricted arms. First, we construct the overall conditional
mean model µ̂res2,a2 with patients who have received viable treatment routes. Then,
we separate the observations into M + 1 groups so that patients with A1 = b1,m are
allocated to the mth group and the rest of the patients are in the 0th group. We define
the truncated patient history, treatment set and treatment rules as follows. For the
70
0th group:
Hres02 = H2 r {(b1,m,XT2 ) : m = 1, ...,M};
Ares02 = A2;
Gres02 = {gres2 : Hres02 7→ Ares02 }.
For the mth group:
Hresm2 = {(b1,m, XT2 )};
Aresm2 = A2 r {b2,m};
Gresm2 = {gres2 : Hresm2 7→ Aresm2},
m = 1, ...,M .
Group specific propensity scores are estimated using data from patients who re-












2 ) , A2 ∈ Aresm2 and Hres2 ∈ Hresm2, m = 1, . . . ,M
.
Then, separate T-RL models are fitted given corresponding estimated conditional
mean model and propensity score model using patient observations in each restricted
groups (from 1st to M th group) that have a2 = (b1,m, c2,m), where c2,m 6= b2,m, to
maximize the pseudo outcome at stage 2. We use all patients in the 0th group to fit
the remaining T-RL model, since all observed treatment sequences in this group are
compatible to those of our interest.
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2 )I{gres2 (Hres2 ) = a2}
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where m = 1, ...,M , nres,m,2 is the number of patients in the mth group with A2 6= b2,m
while nres,0,2 is the number of patients in the 0th group. We define Hres2 = Hres0,2∪Hres1,2∪
... ∪ HresM,2. Since the recommendations are given conditional on A1, all patients are
guaranteed to receive applicable guidance from ĝres,opt2 .
At stage 1, we perform backward induction to estimate the optimal decision rule.




∣∣A2 = ĝres,opt2 (Hres2 ) ,Hres2 } = µ̂2,ĝres,opt2 (Hres2 ) ,
which is the estimated potential outcome one would have observed if the future treat-
ments at stage 2 are already optimized by ĝres,opt2 . ĝ
res,opt
2 consider only applicable
treatment routes and Hres2 covers all patients because there is no restriction on A1.
Moving backward, at stage 1, we don’t have any constrains on H1 and G1. Hence,





1 |A1 = a1,H1). The estimated









1 (H1) = a1}
]
.
In practice, we use a modified version of the pseudo outcome [33] to reduce the bias
due to possible model misspecification from the conditional model. P̃O
res
j is calculated
with the pseudo outcome for previous stage minus the expected outcome gain from
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for j < T . With backward induction and defining P̃OT = Y , it is easy to show that:
P̃O
res
























where π̂1,A1(H1) and µ̂1,g1(H1) are estimated conditionally using all records.
3.2.3.1 Example to Illustrate the RT-RL Process
Figure 3.1 illustrates a 2 stage 3 treatments per stage RT-RL patient allocation
procedure with a restricted arm A1 = 1, A2 = 2. At the second stage, patients with
A1 = 1 are allocated to the 1
st group for at risk of receiving the restricted arm. We
use patient records with A1 = 1, A2 6= 2 to fit the T-RL that seeks personalized
optimal treatment among A2 = 0 or A2 = 1 for patients in group 1. Then, we correct
the pseudo outcomes for patients in the restricted arm with P̃O
res
1 so that they can
contribute to the first stage optimal treatment estimation. The rest of patients are
allocated to the 0th group where a normal T-RL is fitted with no restrictions. The
treatment regimes estimated by RT-RL provides viable treatment recommendations
to future patients based on past treatment sequences.
Through this process, we utilized the observed data of the patients in the restricted
route before their last stage to provide better estimates of gres,opt1 and avoid selection
bias in the study population. In the meanwhile, the above process accommodates the
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Figure 3.1: Patient allocation for a 2 stage 3 treatments per stage RT-RL estimation
with inapplicable route A1 = 1, A2 = 2.
restrictions during the optimization procedure and guarantees the estimated optimal
regime is interpretable and viable in practice.
3.2.3.2 RT-RL Alogorithm
We summarize the RT-TL process for T ≥ 2 stages considering restricted routes
bm,j = (b1,m,j, ..., bj,m,j), j = 1, .., T and m = 1, ...,M with the following Algorithm.
[1]. Input: Outcome Yi, patient character Xij and treatment received ai1, ..., aiT , where i =
1, ..., n and j = 1, ..., T ; restricted routes bm,j = (b1,m,j, ..., bj,m,j), j = 1, .., T and m =
1, ...,M ; n0, d and λ for tree pruning.
[2]. Restrict the patient records considering ai,(T−1) and obtain HresT . Estimate
µ̂resT,aT (H
res
T ) for and aT = 1, . . . , KT using all records.
[3]. Group subjects into the 0th group when AT−1 6= bm,T−1∀m. Classify subjects
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T ) , ..., π̂
M
T,AT
(HresT ). In the m
th group, the propensity model is fitted
with subjects with aT 6= bm,T considering viable candidate treatments.
[4]. Fit separate T-RL models given (n0 , d and λ) for each group with group specific
propensity models and µ̂resT,aT (H
res
T ). Obtain g
res,opt
T by combining the rules of all
M + 1 groups conditional on aT−1.
[5]. For j = T − 1, T − 2, ..., 1 do
(a). With obtained ĝres,optj+1 , we calculate P̃Oj with P̃Oj+1 among patients with












j+1) with random forest model predictions. Then, for patients
with aj+1 /∈ Aresj+1 and aj ∈ Aresj , we estimate the modified pseudo outcome
at stage j with Ê(P̃Oj|Hresj ) using the P̃Oj we just calculated.
(b). Restrict the patient records considering ai,(j−1) and obtain Hresj . Estimate
µ̂resj,aj(H
res
j ) for and aj = 1, . . . , Kj using all records.
(c). Group subjects into the 0th group when Aj−1 6= bm,j−1∀m. Classify sub-
jects into the mth group when Aj−1 = bm,j−1. Then we estimate group










(d). Fit separate T-RL models given (n0 , d and λ) for each group with group
specific propensity models and µ̂resj,aj(H
res
j ). Obtain g
res,opt
j by combining
the rules of all M + 1 groups conditional on aj−1.
[6]. End For





We conduct simulate a studies to evaluate the performances of the proposed RT-
RL compared to a näıve method with regular Reinforcement learning method that
deletes all patients in the restricted arm. We consider 2 treatment stages (T = 2), and
3 treatments (K = 3) per stage (Aj ∈ {0, 1, 2} for j = 1, 2) and one restricted treat-
ment route (A1 = 1 and A2 = 2) Specifically, the simulation study is designed so that
patients in the restricted treatment route have better outcomes and healthier baseline
conditions. The results are examined by the agreement between DTR recommended
treatments and optimal treatment routes excluding A1 = 1 and A2 = 2.
We generate 3 continuous covariates (X1, X2, X3) independently fromN(0, 1). The
clinical outcomes are generated from the sum of rewards at each stage (Y = Y1 + Y2)
preferable with higher values. The treatment A1 is generated from a multinomial
distribution P (A1 = k) = πk1, k = 0, 1, 2 with
π01 =
p11
p11 + p21 + 1
, π11 =
p21
p11 + p21 + 1
, and π21 = 1− π01 − π11,
where p11 = exp{−0.2X1 + 0.3X2 − 0.2I(X3 > −0.5) + 0.5},p21 = exp{0.3X2 +
1.5I(X3 > −0.5) + 0.5}. The underlying optimal treatments for stage 1 follow a rule:
gopt1 (H) =

0 X1 < 0, X2 < 0
1 X2 ≥ 0
2 X1 ≥ 0, X2 < 0
The rewards at stage 1 are defined generated as follows:
Y1 = exp(1 + 0.05 ∗X2 − 2 ∗ |A1 − Aopt|) + ε, ε ∼ N(0, 0.5).
To mimic a typical setting where some treatments with worse side effects may per-
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form better on the targeted clinical outcome, we allow, a large portion of patients
to receive the restricted treatment sequence in this simulation, so that we observe
a better clinical outcome for them. We allocate the treatment at stage 2 condi-
tional on A1 such that patient who has a greater possibility of receiving the re-
stricted arm when A1 = 1. A2 follows a 3-level multinomial distribution with corre-









, where p12 =
exp {0.05Y1 − 0.05X1 − 0.2I (X3 > −0.5)− 1} and p22 = exp{0.08Y1−0.2X1−0.1I(X3 >

















where p′12 = exp(−0.2Y1− 0.05X1 + 4), p′22 = exp(−0.08Y1 + 0.6X1 + 3). The optimal
treatment regime for stage 2 permits higher rewards in the restricted route:
gopt2 (H|A1 = 1) =

0 Y1 ≤ 0.5
1 0.5 < Y1 ≤ 1.5
2 Y1 > 1.5
gopt2 (H|A1 6= 1) =
0 X2 > −0.51 X2 ≤ −0.5
The rewards are then defined as:
Y2 = exp{1 + I(X3 > −0.5) ∗ I(A1 = 1)− 6 ∗ exp(|A2 − gopt2 (H)|)}+ ε,
where ε ∼ N(0, 0.5). When observed with a higher Y1, at stage 2, the optimal
rewards for patients in the restricted route are E[Y2|A1 = 1, A2 = gopt2 (H) = 2] = e2,
which is higher than that of the patients in the applicable routes E[Y2|A1 6= 1, A2 =
gopt2 (H)] = e
1.
We compare our method with a naive method where all patients on the restricted
arm are deleted from the estimation and a regular reinforcement learning method
is directly applied (naive T-RL). In both the näıve and Restricted T-RL, we utilize
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AIPW version of the purity measure to allow robust estimation for pseudo outcomes.
We set the minimum size of terminal nodes as 20, specify λ as 5% in the splitting
criteria, and the maximal depth as three. One hundred replications are generated
under each scenario considering different training sample size (n = 3,000, 5,000), and
different propensity score model specifications (correct or incorrect). All estimated
DTRs are evaluated on the agreement of the estimated and the true constrained
optimal treatments of a randomly generated external test dataset with n = 1,000.
The optimal regime for each patient is calculated empirically using the underlying
rewards functions.
Table 3.1 summarizes the simulation results. Opt % shows the empirical mean of
the percentage of subjects correctly classified to their constrained optimal treatments.
Both methods perform well in the first stage, correctly specifying the true optimal
treatment over 99% of patients. However, for the second stage and overall, the Re-
stricted T-RL has significantly higher opt % than the näıve method. Both regimes
improve patient outcomes, and the proposed algorithm has slightly lower improve-
ments without recommending the restricted arm to future patients. Although deleting
the patients in the restricted arms, the näıve method recommends the inappropriate
treatment combination to 39-42% of patients in the test set. As demonstrated in the
simulation results, both methods are doubly robust as similar results are observed
under the correctly or incorrectly specified π model.
3.4 Application Adolescents Substance Use
We use a longitudinal observational dataset (n = 10,131), known as the Global
Appraisal for Individual Needs (GAIN) [15], to estimate an optimal two-stage DTR
to guide the level of care (LOC) placement for adolescent substance users. The
DTR guides LOC placement over 0-3 months (stage 1) and 3-6 months (stage 2) to
optimize substance use at month 12 after initial treatment. The observed possible
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Table 3.1: Comparing simulation results between Restricted T-RL and the naive
method. Standard errors are recorded in parenthesis. Opt % records the average
percent of subjects in the test set that has being recommended the true optimal
treatment route. Ê (Y |ĝopt)− Ê
(
Y
∣∣gobs) is the improvement of the estimated pseudo
outcomes when following the estimated DTR versus the observed DTR. % of Recom-
mendation with Restricted Arm shows the percent of subjects in the test set that has
been recommended the restricted treatment arm.
Correct π Incorrect π
Method Restricted T-RL Näıve T-RL Restricted T-RL Näıve T-RL
Training Sample n = 3000
Opt % Stage 1 99.3 (0.43) 99.3 (0.49) 99.1 (0.64) 98.6 (5.17)
Opt % Stage 2 81.2 (15.7) 29 (10.6) 78.9 (17.0) 29.2 (11.1)
Opt % Overall 80.9 (15.6) 28.6(10.7) 78.5 (16.9) 28.4 (11.4)
Ê(Y |ĝopt)− Ê(Y |gobs) 1.2 (1.6) 1.3 (1.6) 1.2 (1.6) 1.2 (1.6)
% of Recommendation
with Restricted Arm
0 38.9 0 38.8
Training Sample n = 5000
Opt % Stage 1 99.4 (0.30) 99.4 (0.37) 99.3 (0.39) 99.1 (0.64)
Opt % Stage 2 88.1(13.4) 32.0 (9.2) 85.4 (15.3) 31.8 (9.6)
Opt % Overall 87.8 (13.3) 31.6 (9.2) 85.0 (15.3) 31.4 (9.7)
Ê(Y |ĝopt)− Ê(Y |gobs) 1.2 (1.6) 1.3 (1.5) 1.3 (1.6) 1.3 (1.5)
% of Recommendation
with Restricted Arm
0 41.6 0 40.8
LOC treatment options at stage t (t = 1, 2) are inpatient (At = 1) and outpatient
(At = 2); stage 2 also includes no treatment (At = 3). These treatment options
report whether patients have received corresponding levels of care during each three-
month period. Inpatient or residential is the most intensive treatment, where youth
are admitted for at least one night to a residential, inpatient or hospital program
for substance use problems. Outpatient records youth who have been admitted to a
regular (1-8 hours per week) or intensive outpatient (more than 8 hours per week)
program. The outcome of interest for this study is Substance Frequency Scale (SFS)
at 12 months after intake, which is coded as Y = −1×SFS to ensure that the higher
value is preferable.
We constrain the optimization over A2 ≤ 2 given A1 = 1 by not allowing “treat-
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ment discontinuation” for adolescents starting with inpatient treatment. According
to NIH, since relapse often occurs for adolescents with substance abuse, more than
one episode of treatment may be necessary [27]. Also, inpatient treatment is recom-
mended for a severe level of addiction. Staying in treatment for an adequate period
of time is especially important for patients with A1 = 1.
We randomly split the data 3:1 for training and evaluation. The training data
contain randomly selected 7,599 records, and the remaining 2,532 records form the
evaluation data. This facilitates inference in the comparison of the Restricted T-RL
with näıve T-RL and non-dynamic regimes such as A1 = A2 = 1 and A1 = A2 = 2.
The näıve T-RL excludes 404 patients who received the inapplicable treatment route
A1 = 1, A2 = 3. Better interpretability of ĝ
opt provided by the T-RL methods can
be assessed with lower probability of recommending the restricted route to patients
in the evaluation set. Moreover, we compare Ê (Y |ĝopt)− Ê
(
Y
∣∣gobs) and the percent
of patients who have Ê (Y |ĝopt) > Ê
(
Y
∣∣gobs) among estimated ĝopt to examine the
ability to provide optimal treatments of each method.
Figure 3.2: Estimated DTR from Restricted T-RL and Näıve T-RL. sfs8p t: -1*
SFS at t months post intake, higher value preferred; lri : living risk index, lower value
preferred; dss: depressive symptom scale, lower value preferred.
According to Figure 3.2, the Restricted T-RL provides interpretable DTR based
on SFS at intake (sfs8p 0), living risk index at (lri7 0) intake and first stage treatment
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(A1). It recommends A1 = A2 = 1 to 947 (37.4%) patients and A1 = A2 = 2 to 1,585
(62.6%) patients in the evaluation data. Although deleting all patient records in the
restricted arm, the näıve T-RL allows “treatment discontinuation” for patients who
greatly improved their SFS at month 6, which leads to 674 (26.6%) patients being
recommended with the inapplicable arm in the evaluation set.
Table 3.2 shows that the Restricted T-RL provides a regime in the desired class
with the greatest improvement (0.7 points) in estimated substance use score at 12
months post intake. It is expected to help 56% of patients improve their substance
use outcomes compared to the observed treatment. The näıve T-RL is unable to
provide an interpretable and well-performing regime due to the bias introduced by
the deletion of patients.
Table 3.2: Treatment regime performance on evaluation data. % improved refers
to the percent of patients who are expected to benefit from the estimated regime
compared to the observed treatment.
Restricted T-RL Naive T-RL A1=1, A2=1 A1=2, A2=2





0.70 (1.4) -0.08 (1.9) -0.03 (1.9) 0.14 (1.1)
% improved 56.0 38.6 39.8 42.3
3.5 Discussion
The proposed method Restricted T-RL searches for interpretable DTR within clin-
ically meaningful treatment trajectories. It allows user specified restrictions for ob-
served treatment routes. According to simulation and GAIN data application results,
Restricted T-RL avoids selection bias by using partial information from patients in
the restricted arm to estimate optimal treatment decisions for stages before their first
problematic treatment. We achieve this by “correcting” the counterfactual rewards
of the patients in the restricted arms using information from similar patients who
received applicable treatments. The idea of stratifying based on patient history and
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truncating treatment options is not limited to tree-based methods. Such sub-optimal
DTR estimation framework can be applied to other methods when appropriate.
The näıve T-RL method suffers from information loss and possible selection bias,
yet still recommends inapplicable treatment routes to new patients. This happens
because the rules are estimated stagewise and the naive method considers all observed
treatments in the current stage as possible treatments. Without conditioning on
previous treatment sequences and without restricting the final stage treatment space,
it is not guaranteed that the recommended treatment is different from bj,m,j when the
previous recommendations are aj−1 = (b1,m,j, .., bj−1,m,j).
In this study, we focused on constraints with inapplicable treatment sequences.
This provides a solution for many observational studies with a relatively large sample
size. However, when we have little observational data in any of the 0th to M thj group,
the Restricted DTR is hard to estimate. We might consider parametric models for
these subgroups or bootstrap techniques to handle insufficient data. Moreover, the
treatment sequence constrains can also come from patient characteristics or stagewise
rewards (Rj). For example, if future treatments must consider whether a patient is a
responder to current treatment at stage j, all DTR ignoring the responder status at
stage j should be restricted. Further studies are necessary to solve this issue.
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CHAPTER IV
DataSifterText: Partially Synthetic Text
Generation for Sensitive Clinical Notes
4.1 Introduction
The broad adoption of electronic health records (EHRs) responds to a significant
public demand for rapid data-driven scientific investigations using the wealth of newly
available data and the spectrum of innovative data science methods [13, 20, 21].
However, regulatory policies and social norms regarding concerns for data privacy
hinder efficient data sharing, which results in a scarcity of available data for research
purposes.
EHR data broadly falls into two categories: structured and unstructured data,
structured data being numerical or categorical information, while unstructured data
include physician notes, such as free-text or voice notes. Clinical narratives provide
valuable information and have become an essential component in many biomedical
data sources. The recent success in natural language processing (NLP) techniques
has generated much interest in processing and analyzing unstructured clinical data.
Safe and rapid sharing of unstructured medical information is difficult to achieve.
Generalizing and suppressing names, addresses, and other protected health informa-
tion (PHI) is a common practice in creating anonymized clinical notes [25, 38, 9].
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Recent studies have automated the procedure of searching for PHI and suppressing
information by applying deep learning techniques [16, 98]. However, on the one hand,
sensitive personal identity information in EHRs may still be obtained from detailed
descriptions in narrative reports. On the other hand, when completely suppressing
all sensitive PHI, de-identified medical records contain little analytical value.
In 2018, Jiaqi Guan et al. developed medGAN [29], a synthetic EHR text gen-
eration tool based on Generative Adversarial Network that utilizes long short-term
memory (LSTM) as the text generator and fastText, convolutional neural network,
and bidirectional recurrent neural networks as candidate discriminators. MedGAN
can create fully synthetic EHR text from pre-specified disease features extracted from
original text data. Yet despite little concern in disclosure risk, the data governor may
face multiple challenges when generating fully synthetic text data to meet analytic
goals. First, since text generation from medGAN is based on disease features, the
generated fully synthetic data of “fake” patients might not represent the target pop-
ulation. Second, the LSTM model might suffer from insufficient data so that it fails
to capture the conditional distribution of the real-world EHR text. In this scenario,
fully synthetic text documents have limited data utility.
The first limitation is also applicable to fully synthetic structured datasets. In
1993, Rubin first proposed partially synthetic data generation for structured data
[70], which provides a set of multiple-imputed data replacing sensitive data values
with imputations. This method retains the distribution of the target population but
provides data privacy by replacing sensitive values with a group of similar alternatives
[57, 58]. In a recent report, the DataSifter technique (DataSifter I) [45] provides a
semi-automated procedure to create a single partially synthetic dataset that disguises
the replaced value locations and provides better privacy protection than the multi-
ple imputation methods. The DataSifter I technique depends on two major steps:
(1) introducing random artificial missingness to the original data and imputing the
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missingness back using a robust iterative imputation method; (2) classifying neighbor
cases for each record and randomly swapping a subset of feature values between sim-
ilar records. The first operation masks true information sporadically and the second
operation guarantees partial obfuscation for each record while preserving the data’s
geometrical information in feature space.
The second challenge of limited EHR text data can be handled by Bidirectional
Encoder Representation from Transformers (BERT). The BERT model is the state-
of-the-art language representation trained on 3,300M words that depends on multiple
attention layers to provide a deep bidirectional language representation that suits
multiple downstream tasks[17]. It has excellent performance on small datasets un-
der different NLP tasks with its transformers model architecture stacking multiple
attention layers.
However, there are no existing methods for generating partial synthetic unstruc-
tured data. In this chapter, we propose a free-text data anonymization tool, DataSifter-
Text, which generates partial synthetic free-text data that protects patients’ PHIs.
Analogous to DataSifter I, the proposed method depends on two major steps: ar-
tificially masking/predicting sensitive tokens and replacing content with neighbor-
ing documents. To fill in the masked tokens (words, phrases or punctuation), the
DataSifterText technique utilizes the BERT model. We applied the DataSifterText
protocol to work injury records and clinical notes from EHR data to demonstrate the
use of DataSifterText on sensitive free-text data.
4.2 Free-text Data Structure
Let us assume we have a corpus of text data consisting of n documents. The corpus
can be one-hot encoded by representing each token (word or punctuation) as a vector
of binary indices. We denote the ith document by Wi = (w1, w2, w3, . . . , wTi) ∈ W ,
where w1 is the “start of sentence” one-hot vector, wTi is the “end of sentence” one-
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hot vector, Ti is the length of the document, and wt,∀ t ∈ {2, . . . , (Ti − 1)}, is the
one-hot vector for the matching word token at location t.
One common goal of a text mining algorithm is to derive corresponding classifica-
tion labels (L = (L1, . . . , Ln)) associated with each text document in the corpus. For
example, in EHRs, each patient’s clinical notes are linked with International Classi-
fication of Diseases (ICD) diagnostics, from which we can calculate the comorbidity
score level as labels to represent the patient’s health condition at the hospital visit
[11].
Our goal is to utilize the joint distribution of tokens for documents in the corpus
to create the partially synthetic (sifted) data. For instance, the distribution of the ith
document denoted by Wi = (w1, w2, w3, . . . , wTi) may be modeled as:
P (w1, w2, w3, . . . , wTi) = P (w1)
Ti∏
k=2
P (wk|w1, . . . , wk−1)
= P (w1)P (w1)P (w1, w2) . . . P (wTi |w1, . . . , wTi−1) .












which shares a similar distribution with Wi. When the perturbation is significant, the
sifted text will move away from the original document to protect subject information
disclosure.
4.3 Privacy and Utility Definitions for Partially Synthetic
Text Data
Data privacy for each document is quantified using the cosine similarity between
the Document-term Matrix (DTM) [72, 97] entry of the original and the sifted doc-
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uments. If we define D1︸︷︷︸
n×m
as the DTM for original data considering most frequent m
terms and D2︸︷︷︸
n×m




‖ D1i ‖‖ D2i ‖
,
where D1i, D2i are the i
th row in the original and sifted DTM.
Data utility is measured by the label prediction results from a BERT model [17]
denoted by f : W → L, where W is the set of possible documents and L denotes
the set of labels. Using the original free-text data, we fine-tune the BERT model
(multilingual cased BERT-Base, which is pre-trained by text in 104 languages, using
12 layers, 768 hidden layers, 12 heads, and 110M parameters) using label prediction
as the downstream task. We denote the original prediction results as f (Wi) ∈ L and
the sifted data prediction results as f (W ∗i ) ∈ L for document i = 1, . . . , n. Data
utility is calculated by the mean label prediction accuracy 1
n
∑n
i=1 I [f (W
∗
i ) = Li]
and the mean label prediction agreements 1
n
∑n
i=1 I [f (Wi) = f (W
∗
i )], where both
measurements are preferable with higher values. When we have informative data and,
as a result, an accurate BERT model, the utility of the partially synthetic dataset can
be directly assessed by label prediction accuracy. We can rely more on the mean label
prediction agreements when the original BERT model cannot successfully capture
the map between documents and labels. Note that if Wi and W
∗
i share the same
class label, the subsequent prediction results under the same BERT model should be
similar. For f (Wi), the training and prediction data may be shared, but overfitting




4.4.1 Masking and Prediction
Analogous to DataSifter I imputation step, we create artificial missingness in each
document and impute the missingness back with a trained language model. The goal
of this step is to substitute sensitive tokens with similar phrases to protect personal
information. The artificial missingness was created by replacing original text with the
“[mask]” tokens. Then, the “[mask]” tokens will be imputed by BERT trained from
the original data. We have chosen BERT as our language model for mask prediction
because one of its embedded tasks for parameter training is predicting words in a
blank. Moreover, the pre-trained BERT model provides a sufficient language model
for relatively small data.
Generally, personal information in free-text documents is stored only in specific
terms. Masking words in a random manner might be inefficient to protect privacy.
Thus, we embed a blacklist and a whitelist for masking. The algorithm avoids masking
word tokens in the blacklist (usually includes standard punctuation or stop words),
while the word tokens in the white list are masked with higher probabilities. For
EHRs, it is suitable to include medical-related terms in the whitelist. Deep learning
techniques can also be applied for constructing a data specific whitelist that covers
more PHI. The proposed algorithm caps the number of “[mask]” tokens to be as-
signed in a document by (number of words)×0.5 and avoids consecutively masking
by dynamically adjusting masking probabilities. Both settings provide context for
the language model to make accurate predictions for masked locations.
4.4.2 Document Obfuscation
In the obfuscation step, we replace part of each document with text in similar
documents. To find the contents in each document that needs to be replaced, we apply
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Rapid Automatic Keyword Extraction (RAKE) algorithm [67] or TextRank [49] to
identify the most important key phrase or key sentence. The RAKE approach parses
each document with stop words and punctuation to search for candidate key phrases.
To quantify the importance of each key phrase, RAKE derives a summarized score
using the word frequency and degree or co-occurrence score. TextRank is a graph-
based ranking model for text summary. It uses content overlap between sentences to
rank the importance of each sentence.
With shorter documents, we provide two possible methods to find the contents
for replacement. The first method only considers replacing the top q important key
phrases in the document with that of a similar document. In the second method, we
replace the contents starting from the first index of the most important key phrase
recognized by RAKE to the end of the sentence, which offers a higher level of ob-
fuscation. When longer documents are observed, TextRank is utilized to identify the
most important sentences in the documents for replacement.
The similarity of two documents is measured by the cosine distance of their entries
in the Document-term Matrix (DTM) [72] using the term frequency-inverse document
frequency (TF-IDF) scheme [97]. For data with a larger number of documents, we
apply Mini Batch K-means on DTM to group documents into smaller clusters and
search for neighboring documents within each cluster.
4.5 Implementation of DataSifter Unstructured
The input text and corresponding labels are denoted by W = (W1, . . . ,Wn) and
L = (L1, . . . , Ln), respectively. In the masking and prediction step, we use parame-
ters pw and pn to control for the masking probability in whitelist and blacklist. We
denote D (W,m) as the function to create a DTM using the TF-IDF scheme and most
frequent m terms with documents in W. D (W,m)i denotes the i
th row of the DTM.
We denote RAKE (W ) and TR (W ) as the RAKE algorithm and the TextRank algo-
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rithm applied to text corpus W, correspondingly. We further denote RAKE (Wi)q as
the top q important key phrases and TR (Wi)q as the top q important sentences forWi.
The input replacement method is a tuple with four options (RAKE keyphrase, q),
(RAKE index, 1), (TextRank, q) and (No obfuscation, 0) that specifies the content
extraction method for the obfuscation step. Our DataSifterText protocol is imple-
mented in Python 3.6.
Algorithm 4 DataSifterText - Masking and Prediction
1: Input: W, L, blacklist, whitelist, pw, pn, and replacement method.
2: Construct BERT on documents with downstream task as blank words prediction.
3: for i = 1, .., n do
4: Set nmask = 0, coef = 1.2.
5: while nmask ≤ 0.5 ∗ Ti do
6: for t = 1, ..., Ti do
7: if wt ∈ whitelist then
8: Set p = 1− pw ∗ coef.
9: else if wt ∈ blacklist then
10: Set p = 0.
11: else
12: Set p = 1− pn ∗ coef.
13: end if
14: Mask wt with probability p.
15: if wt is masked then
16: nmask = nmask+1
17: coef = 1.2
18: else if coef > 0.05 then





24: for i = 1, .., n do
25: for t = 1, ..., Ti do
26: if wt = [MASK] then
27: Use trained BERT model to generate P (wt|Wi).
28: Sample one token with the obtained distribution P (wt|Wi) and replace





Algorithm 4 DataSifterText (continued) - Document Obfuscation
32: if Replacement method 6= (No obfuscation,0) then
33: Construct D(W,m).
34: Use Mini Batch K-means to classify documents into K clusters.
35: Obtain RAKE(W) or TR(W) based on replacement method specification.
36: for i = 1, ..., n do
37: Sample min(1, 000, nWi) documents in the same cluster as Wi, where nWi
is the number of documents in the same cluster as Wi, such that the document
index j 6= i.
38: for j = 1, ..., 1, 000 do




41: Sample one document from {Wj : dist(i, j) within the smallest top 10% ∀j}
as the replacement partner for document i and denote as Wj∗.
42: if Replacement method = (RAKE keyphrase, q) then
43: Replace RAKE(Wi)q with RAKE(Wj∗)q
44: else if Replacement method = (RAKE index, 1) then
45: Replace all tokens from RAKE(Wi)1 toWTi with RAKE(Wj∗)1 toWTj∗
46: else




51: Output: W∗ = W, and L∗ = L
4.6 Application
4.6.1 CDC Data
Work-related injury records are generated every day. In 2019, the Centers for
Disease Control and Prevention (CDC) National Institute for Occupational Safety
and Health (NIOSH) launched a text classification challenge to automatically classify
injury records according to the Occupational Injury and Illness Classification Sys-
tem (OIICS) [23]. There are 153,956 injury records in the CDC data with injury
descriptions in text, gender, age, and OIICS labels. We applied DataSifterText to
a subset of records (n=86,666) with the five most frequent OIICS labels, including
overexertion involving outside sources (71), struck by object or equipment (62), falls
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on same level (42), exposure to other harmful substances (55), and struck against
object or equipment (63). The average length of the injury description is 18 words
with a minimum of 3 words and a maximum of 37 words. The entire corpus contains
24,004 distinct terms.
We used the DataSifterText technique to construct partially synthetic datasets
and examined their privacy and utility performances. In the application, we con-
sidered three obfuscation levels of the DataSifterText using the following parameter
settings: low obfuscation (pw = 0.5, pn = 0.75, and replacement method = (No ob-
fuscation, 0)); medium obfuscation (pw = 0.5, pn = 0.75, and replacement method =
(RAKE keyphrase, 1)); and high obfuscation (pw = 0.5, pn = 0.75, and replacement
method = (RAKEindex, q)). As a result, during the masking and prediction step,
the tokens in the whitelist were masked with probability 1 − 0.5 × coef , whereas
the normal tokens excluded from the whitelist and blacklist were masked with prob-
ability 1 − 0.75 × coef . We did not consider using TextRank as the replacement
method in the obfuscation step, since the CDC data contains only one sentence per
document. We compared the DataSifterText method with a naive method that sup-
presses the masked information such that the artificially masked or obfuscated tokens
are not replaced. To measure data utility, we first constructed a BERT language
model (f(·)) with the downstream task as label prediction based on the original
CDC data and obtain OIICS label predictions f(Wi) for i = 1, ..., n. After gen-
erated the sifted data, we assessed the utility of the synthetic data by calculating
label prediction accuracy ( 1
n
∑n
i=1 I [f (W
∗




i=1 I [f (Wi) = f (W
∗
i )]), using the constructed BERT model. The data privacy
protection for each sifted document was measured by the cosine distance between the
original and sifted DTM entries. We chose m= 5,000 most frequent terms to limit
the size of DTM for original and sifted text corpus.
The application results imply that the text in the sifted data was significantly
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altered, yet it maintained a high level of data utility. The BERT model for label
prediction (f(·)) constructed with the original data predicts OIICS labels with 95.7%
accuracy on a n = 1,000 test data, which indicates the language model has a good un-
derstanding of the injury description. The distribution of OIICS labels and prediction
accuracies are shown in Table 4.1. For most labels, BERT had excellent prediction
accuracy (around 95%) on the test sample. As an exception, for label 63 (struck
against object or equipment), the BERT prediction had 86.1% accuracy, probably
due to the lack of data.
Table 4.1: Distribution and BERT prediction accuracy for OIICS labels.
Label 42 55 62 63 71
Count (%) 15,624 (18.0) 11,672 (13.5) 24,402 (28.2) 9,058 (10.5) 25,910 (29.9)
Prediction Accuracy % 97.8 98.2 94.0 86.1 98.6
Examples of the original, sifted, and naively suppressed texts under different ob-
fuscation levels are demonstrated in Table 4.2. The masking and prediction step
with the specified parameter settings masked 3 tokens on average or 18.57% of the
tokens in each document. In addition to the masking and prediction step, the medium
and high obfuscation applied document obfuscation step with RAKE keyphrase and
RAKE index methods, respectively. It is noticeable that higher obfuscation levels are
associated with more replacements among words in the sifted text.
Table 4.2: Examples of original and sifted partially synthetic data. The bolded words
were obfuscated by the masking and prediction step. The italic words in square
brackets were created by the obfuscation step. Abbreviations: FX is short for bone
fracture, and DX is short for diagnostics.
Data Type Injury Description Naive suppressing description
Original Slipped and fell onto shoulder at work FX shoulder NA
Sifted low obfuscation Slipped and fell onto something at work today
Slipped and [mask] onto
[mask] at work [mask]
Sifted medium obfuscation Slipped and [break leg ] at work today
Slipped and [mask] [mask]
[mask] at work [mask] [mask]
Sifted high obfuscation Slipped and [DX ankle foot pain at work fell ]
Slipped and [mask] [mask]
[mask] [mask] [mask] [mask] [mask]
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The data utility of the partially synthetic CDC datasets is summarized in Table
4.3. Label prediction accuracy was calculated by comparing the predicted label for
each document from the BERT model with the ground truth. The original data had
a 98.5% accuracy suggesting nearly perfect training accuracy. The partially synthetic
data achieved 86.6%, 74.5%, and 60.9% of label prediction accuracy from low to
high obfuscation level. We observed a clear separation of utility preservation among
the three levels, and the sifted datasets maintained the high prediction accuracy in
a five-class classification problem. Compared to the naive suppressing method, the
DataSifterText method provided consistently better accuracy across different scenar-
ios and the differences between label accuracies are larger under higher obfuscation
levels. This implies that our replaced tokens in the mask and prediction step pro-
vide informative content that improves prediction accuracy. The label prediction
agreement was similar to the accuracy of all synthetic datasets.
Table 4.3: Data utility for original, sifted and naive suppressing CDC text (n=86,666)
according to the constructed BERT model (f(·)) that maps the CDC injury records
to 5-class OIICS labels. The label prediction accuracy records 1
n
∑n
i=1 I [f (W
∗
i ) = Li]
and the label prediction agreement records 1
n
∑n





















The data privacy assessment for CDC synthetic datasets was performed using the
cosine similarity between the original text and sifted text DTM entries. As illustrated
in Figure 4.1, the mean cosine similarity for low, medium and high obfuscation
levels were 0.73, 0.54, and 0.35, respectively. Under low and medium obfuscation,
the distributions of the cosine similarities were approximately normal. The high
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obfuscation level provided significant alteration in text such that a great proportion
of documents were completely altered from the original text (cosine similarity =
0). The naive suppressing method was expected to provide similar cosine similarity
as the sifted dataset. However, the unmasked tokens in the näıve synthetic data
revealed actual information about the corresponding patients, which yielded higher
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Figure 4.1: Data privacy for partially synthetic CDC datasets generated by
DataSifterText. The cosine similarities were calculated by comparing the DTM en-
tries of the original and sifted text documents. The DTM was constructed using the
original text corpus with 5,000 most frequent terms. The vertical lines indicate the
means of the cosine similarities among different obfuscation levels.
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4.6.2 Clinical narratives in MIMIC III
The Medical Information Mart for Intensive Care III (MIMIC III) provides elec-
tronic health records from a large tertiary care hospital between 2001 and 2012 [34].
MIMIC III data stores information related to patients’ hospital visits, including care-
giver notes, vital signs, medications, laboratory measurements, imaging reports, mor-
tality, and more. In this study, we focused on patient discharge summaries that
describe the reason for the hospital visit, medical procedures performed, medication,
and other clinical narratives related to the hospital stays. The discharge summaries
are on average 220 words long (SD = 238) with minimal 4 words and maximum 3,135
words. To control model complexity and time complexity, we specified the maximum
token length for BERT as 512 tokens per document. Around 9% of the documents
had exceeded the handling limit. Thus, we provided two versions of preprocessing
for the MIMIC III data. In the first version, “original text,” our free-text documents
were capped at 512 tokens deleting exceeding contents. For the second version, “sum-
marized text,” we first used TextRank to rank the sentences and then truncated them
to 512 tokens. The first version retains the normal order of the sentences in the docu-
ments, while the second version keeps the most informative sentences within the word
limit.
We considered a subset of 44,423 hospital visits that covers a variety of disease
categories. Each discharge summary was paired with a Charlson Comorbidity In-
dex (CCI) calculated from the corresponding International Classification of Diseases
Version 9 (ICD-9) codes for diagnosis12. The ICD-9 codes were assigned after each
hospital stay for billing purposes. In the study cohort, patients can be classified into
3 classes of CCIs: 0, 1-2, and ≥3. In the full dataset, 29% of patients belonged to the
0 class, 22% belonged to the 1-2 class, and the remaining patients belonged to the
≥3 CCI class. The MIMIC III clinical narratives contained de-identified data that
masks name, address, dates and other protected health information with generalized
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tags. However, detailed clinical procedures and information including the reason for
the hospital visit, treatment history and allergies may lead to high reidentification
risk.
We aimed to generate partially synthetic datasets using DataSifterText and ex-
amine the corresponding data privacy and utility. For the MIMIC III data, since
multiple sentences are contained per document, we used two obfuscation levels: low
obfuscation (pw = 0.5, pn = 0.75, and replacement method = (No obfuscation, 0)) and
high obfuscation (pw = 0.5, pn = 0.75, and replacement method = (TextRank, 1)).
We applied DataSifterText to both versions of preprocessed clinical text. Like the
CDC application, we calculated the label accuracy and agreement to compare the
data utility and obtained the cosine similarity of DTM entries to compare the data
privacy.
The application data utility results are summarized in Table 4.4. The BERT
model for label prediction constructed using “original text” and “summarized text”
had a training accuracy of 62%, which indicates a fair understanding of the connection
between the free-text and their labels. The two preprocessing methods yielded similar
results under the low (58%) and high obfuscation levels (52%) in terms of label
prediction accuracy. We observed that the reduction in accuracy in the MIMIC III
application was not as significant as the CDC application when the original BERT
model was less accurate. Moreover, we observed high label agreement in all settings
compared to label accuracy, which showed the effectiveness of our obfuscation method.
Specifically, the “summarized text” provided a significant higher label agreement.
We examined the data privacy of partially synthetic data with the cosine similar-
ities of the original and sifted data DTM entries considering the 5,000 most frequent
terms. Figure 4.2 illustrates the distribution of the cosine similarities across different
preprocessing methods and levels of obfuscation. The results were similar for the two
preprocessing methods that low obfuscation provided relatively similar documents
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Table 4.4: Data utility for original and sifted MIMIC III text (n=44,423) accord-
ing to the constructed BERT model (f(·)) that maps patient discharge summary
to 3-class CCIs. Original text was preprocessed by truncating long documents to
512 tokens. Summarized text was preprocessed with the TextRank algorithm and




i=1 I [f (W
∗




i=1 I [f (Wi) = f (W
∗
i )].
Data Type Original text Summarized text
Obfuscation level None Low High None Low High
Label prediction accuracy 63.1% 57.9% 50.5% 62.4% 58.8% 53.3%
Label prediction agreement NA 75.6% 61.9% NA 80.9% 71.6%
with the raw text yielding an average cosine similarity of 0.87 while high obfuscation
altered more information offering an average cosine similarity of 0.63.
4.7 Discussion
In this chapter, we proposed the DataSifterText technique to generate partially
synthetic free-text that enables data-sharing by providing data privacy protection
while maintaining data utility. We also derived measures to quantify data privacy
and data utility for free-text data using the BERT model and DTM. According to
our clinical data applications, the proposed technique protects the distribution of the
original text corpus, offers individual level data obfuscation, and enables collabora-
tive data analytics without compromising personally identifiable information. The
DataSifterText algorithm provides sufficient privacy protection by disguising the lo-
cation of true and obfuscated tokens. The proposed method can be implemented on
multicore parallel programming environments to address scalability issues.
After controlling the maximum document length in BERT models, we prepro-
cessed the original clinical text that exceeds this limit by truncation or summariza-
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Figure 4.2: Data privacy for partially synthetic MIMIC III datasets generated by
DataSifterText. The cosine similarities were calculated by comparing the DTM entries
of the original and sifted text documents. The DTM was constructed using the
original text corpus with 5,000 most frequent terms. The vertical lines indicate the
means of the cosine similarities among different obfuscation levels.
preprocessing for long text, since it contains less noise when modeling the association
between text and labels. However, for some datasets, the original order of the sen-
tences might contain more information than the rank of the sentences. Under such
settings, the data governor could consider using the “original text” preprocessing for-
mat. Future studies might also consider splitting the original text into subtexts and
combining the results back to one document to avoid the truncation of long docu-
99
ments. This approach may require extra steps during the synthetic data evaluation
phase, since the BERT model cannot handle long text.
We chose BERT as a language modeling tool because it represents a state-of-
the-art technique with significantly broad applications and good scalability. The
DataSifterText protocol can also be reimplemented using other language models to
decrease model complexity or handle longer text objects.
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CHAPTER V
Clinical Free-text Information Extraction in
Dynamic Treatment Regime Estimation
5.1 Introduction
Personalized medicine (PM) provides individualized patient treatment recommen-
dations tailoring heterogeneous patient characteristics with specific treatments, unlike
the one-size-fits-all model of care. The dynamic treatment regime (DTR) is an ef-
fective vehicle under PM’s umbrella that offers adaptive treatment strategies [10].
Especially for chronic conditions, a course of medical intervention containing mul-
tiple treatment stages is often needed for patients. In this paper, we demonstrate
the proposed method using a motivating example, where the treatment strategy is
adjusted and adapted over time to control patients’ blood pressure during the first
two days in intensive care units (ICU). We consider four potential classes of antihy-
pertensive agents – angiotensin-converting enzyme inhibitors (ACEI), beta-blockers,
calcium channel blockers (CCB), and diuretics. After a patient is admitted to ICU,
one treatment will be assigned to the patient immediately to control the elevated
blood pressure based on his/her own medical history and clinical evidences. If it
controls the blood pressure, no treatment is needed on day two. Otherwise, we rec-
ommend a subsequent treatment to non-responders. In this example, we have two
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sequential treatment decision stages, and one possible DTR can be: Treat patients
younger than 55 years of age with ACEI and treat the rest of patients with CCB on
day one; then provide CCB for non-responders on day two.
To guide evidence-based effective treatment decisions at each stage, researchers
are developing statistical methods to evaluate and identify the optimal DTR, which
tailor the optimal treatment choice to each individual that maximizes the expected
clinical outcome given the individual’s current disease status and medical history.
Abundant patient information is needed to obtain accurate estimations for the desired
clinical outcomes and provide various candidate tailoring variables while constructing
treatment rules.
Electronic Health Records (EHRs) are major data sources for observational studies
in the biomedical field, including detailed information about patients’ medical histo-
ries (e.g., diagnoses, medications, and test results). As EHRs are adopted widely
across different healthcare institutions, massive amounts of health information are
available to develop, assess and fine-tune the optimal DTRs. Various statistical meth-
ods have been developed for identifying optimal DTRs using observational data in
EHR. Commonly used parametric and semi-parametric methods include marginal
structural models with inverse probability weighting (IPW) [51, 31, 90], G-estimation
of structural nested mean models [63, 64, 65], and targeted maximum likelihood esti-
mations [88]. These methods provide high interpretability but require correct model-
ing assumptions for a sequence of conditional models, which is practically unattainable
for a large number of covariates. To alleviate modeling assumptions and maintain in-
terpretability, Laber and Zhao proposed a tree-based method for estimating optimal
treatment regimens [39]. Tao and Wang generalized the method using the doubly
robust approach and developed Tree-based Reinforcement Learning (T-RL) that sup-
ports multi-stage treatment decision making [84, 85]. However, all existing methods
only consider using information from structured EHR data, which is designed for the
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management of care or billing purposes. When studying a specific disease, critical
patient characteristics might not be available in the structured data, or partial miss-
ingness can occur in such variables. For example, tobacco use is a risk factor for many
chronic diseases, including vascular diseases and lung cancer [3, 22], but structured
EHR data does not include smoking status as a regular entry. Moreover, manual
transcription errors occur in 1-10% of the structured EHR data [46]. For these two
reasons, it is essential to collect various and accurate patient characteristics to select
the correct tailoring variables when constructing DTR. Thus, we consider additional
information from resources other than structured EHR data.
Narrative content in EHR, like clinical notes, represents a reliable supplementary
data resource for critical patient characterization. Information extraction (IE) tech-
niques are well studied in many disease-specific investigations for identifying unique
disease conditions [92]. Most of the IE techniques are rule-based, depending on regu-
lar expression matching. cTAKES is among the most popular IE method facilitating
biomedical studies based on clinical free-text data [73]. It consists of many individ-
ual tools, including sentence boundary detector, tokenizer, named entity recognizer,
and negation recognizer. These individual components can be grouped to handle the
extraction of patient-specific characteristics.
Nevertheless, no existing work has evaluated the benefit of performing clinical
IE using narrative contents in EHR to enhance the accuracy of the estimated DTR
systematically. For this study, we developed a protocol for extracting patient charac-
teristics from the EHR narrative contents to improve DTR estimation accuracy. The
protocol adopts T-RL as a robust and scalable DTR estimation approach. Our ex-
tended simulations demonstrate the benefits of utilizing IE in estimating DTR under
different circumstances. Applying the protocol to the MIMIC-III database, we exhibit
the effective use of IE on estimating an optimal two-stage DTR guiding hypertensive
drug use among critically ill patients with severe acute hypertension.
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5.2 Methods
5.2.1 Information Extraction from EHRs
In this chapter, IE is used to derive structured data from clinical free-text. We
consider using rule-based IE tools that rely on Regular Expressions (REs) [36], which
provide a standard mechanism to select specific strings using a bit pattern from a set
of character strings. With REs, we can successfully search for patient information
with bit patterns consisting of specific keywords and punctuation. Specifically, the
proposed protocol closely follows the cTAKES system [73] and employs the following
individual components: (1) Named entity recognition, which is the core component
to identify and locate the target pieces of information; (2) Boundary detector, which
detects the start and end location of the desired informative substring; and (3) Nega-
tion annotator, which can help determine the yes or no status, when referring to an
identified named entity. The extraction procedure is different for different variable
types. Numeric variables can be extracted using named entity recognition and bound-
ary detector; named entity recognition and negation annotator extracts binary and
categorical variables.
We take four steps to extract patient characteristics from EHR clinical notes using
cTAKES components and REs.
(1) Find sections or headings in the clinical note that might contain the target
information. For example, hospital visit-related information might be located in the
“discharge summary” or “physician notes,” and medication use information may be
found in the “pharmacy” sections.
(2) Detect boundaries of the target information with the boundary detector. Pa-
tient information is usually contained in one sentence or a number surrounded by
word tokens. Identifying the boundaries of the target information helps to further
fine prune the target string. Punctuation including periods and colons and units like
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“lb,” “cm,” and “kg” can indicate the beginning of or the end of the target string.
(3) Search for named entities or target keywords. After obtaining the candidate
strings in specific sections of the clinical notes, we search for relevant keywords in
those strings. For example, if we are extracting patient height, we can search for
“height|ht|hgt,” where “|” is the “or” notation in RE.
(4) Convert target strings into structured data. For numerical information, we
use an ad hoc process by analyzing the possible structures of the target strings and
use REs to extract the numerical values and corresponding units. For binary or
categorical information, we employ the negation annotator to search for negative
tags around (within five tokens) the target keyword. The default status is truth.
Once a negative tag is identified, we determine that the status of the corresponding
condition is false.
5.2.2 Notations and Data Representation
We consider an EHR dataset containing n patients, T treatment stages, and
Kj (Kj ≥ 2) potential treatment options at the jth treatment stage, j = 1, . . . , T .
Patients are observed to follow one of the treatments available at each stage. For
the ICU blood pressure management example, we have T = 2, K1 = K2 = 4. Let
Aj denote the treatment at the j
th treatment stage that may take a value aj, where
aj ∈ Aj = 1, . . . , Kj. Let ĀT ≡ (A1, . . . , AT ) denote the sequence of treatment
indicators until stage T . Similarly, we denote the observed treatment routes with
āT ≡ (a1, . . . , aT ). We use Rj to denote the clinical outcome observed following Aj,
which varies under different patient characteristics Xj and prior treatments received
Āj−1. The overall clinical outcome at stage T is considered a functional of the re-
ward history such that Y ≡ f (R1, . . . , RT ), where f (·) is a pre-specified function
(e.g., sum). We assume Y is bounded and preferable with larger values. Stage-
wise individualized treatment recommendations are inferred from the observed final
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)T ∈ Hj. Using EHR data and our IE procedure, patient
characteristics can be observed from two data components: structured and free-text
data. We denote the patient characteristics at stage j observed in structured EHR
data as Sj = X
S
j ∈ Rns×qs , where Sj might contain sporadic missing values. Let
Tj = X
t
j ∈ Rnt×qt denote the patient characteristics at stage j extracted from the
free-text data. After combining the two components we obtain Xj ∈ Rn×q such that
n ≥ max (ns, nt) and q ≥ max (qs, qt) with potentially more patients and covariates
than XSj . The addition of Tj can help handle missingness and adding extra variables
that are not observed from Sj. With the observed data, we aim to find a sequence
of personalized treatment rules g = (g1, . . . , gT ) that maximizes the expected coun-
terfactual clinical outcome if the g is followed to make treatment decisions, where gj
maps from patient history Hj to potential treatments aj ∈ Aj.
5.2.3 The Estimation of DTR using Tree-based Reinforcement Learning
(T-RL)
We utilize T-RL [85] to estimate the optimal DTR using structured and free-
text EHR data. T-RL is a non-parametric optimization procedure that outputs an
unsupervised decision tree for treatment guidance at each stage, where each fork is
a split in a tailoring variable and each end node contains a recommended treatment
for the corresponding patient subgroup.
When estimating the optimal DTR, we adopt the counterfactual framework for
causal inference defined in Robins, 1986 [62]. Under the three standard assumptions:
consistency, no unmeasured confounding and positivity, we link the counterfactual
outcomes with observed information. At stage T , we denote Y ∗(A1, ..., AT−1, aT )
or Y ∗(aT ) as the counterfactual outcome for patients receiving treatment aT given
previous treatments. We aim to search for optimized treatment regime goptT that maxi-
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mizes expected counterfactual outcome. Using backward induction, at stage j(j < T ),
we maximize the counterfactual outcome when all future treatments are optimized,




T ). However, such counterfactual outcome
is not observable for all patients. We estimate stage-wise pseudo-outcome denoted as




T )] to approximate the target outcome and obtain
goptj . T-RL uses doubly robust AIPW estimates for patients’ counterfactual outcome
and pseudo outcome under all possible treatments.
The T-RL algorithm seeks the optimal regime with a sequence of treatment de-
cision at each stage by constructing a binary tree. At any stage, we use Ê[Yi(a)] to
denote the estimated pseudo outcome for patient i = 1, .., n given treatment a ∈ A.
For considering each split that separates patient group Ω into ω and ωc, the T-RL
compares



















to decide if split is needed. When P(Ω, ω)− P(Ω, φ) is meaningfully large, the algo-
rithm will make the partition with the corresponding tailoring variable and optimal
treatments (a′ and a′′). To avoid overfitting by pruning the tree, we use stopping rules
which consider the minimal node size, minimal improvement for P(Ω, ω) − P(Ω, φ),
and maximum depth of the tree.
5.3 Simulation
We simulated a 2 stage (T = 2), 3 treatments per stage (K1 = K2 = 3) obser-
vational study and its corresponding EHR data to evaluate the benefit of using IE
in estimating optimal DTRs. The full data contains the stage-wise rewards (R1, R2),
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treatment received (A1, A2), 3 complete structured patient characteristics X1, X2, X3,
and 2 patient characteristics that can be extracted from the clinical narratives: weight
in pounds (X4) and current smoking status (X5), where X4 is in pounds and X5 is
binary. In the simulation, we considered cases where X4 contains missing values or
has entry errors and X5 is not observed in the structured data. Then, we compare
the DTR estimation performance with and without IE under above cases.
To create a scenario with simulated clinical text, we first sampled 27,707 discharge
summaries from the Medical Information Mart for Intensive Care III (MIMIC-III)
data [34] that contain information about weight but do not contain smoking status.
Then, we randomly inserted information in a random set of text documents to create
simulated clinical notes with patients’ smoking information. The inserted information
included smoker tags like “10 pack-year smoking”, “cigars daily”, “heavy smoking”
and non-smoker tags like “tobacco: denies” and “former smoker”. As a result, we
simulated 45% smokers in our study population.
For all simulation cases, X1, X2, X3 were sampled independently from N(0, 1).
When we observed weight information in the text, the true X4 value agreed with the
text information, otherwise it was sampled from N(195, 51), which approximates the
weight distribution observed in the clinical text. The true X5 is 1 when we assign a
smoker tag to a patient record and 0 otherwise. We set A1 = A2 = {0, 1, 2}. In the
first stage, the treatments A1 followed a Multinomial(π01, π11, π21) distribution where
π01 =
1








exp(0.005X4 + 0.5X5) + exp(0.5X3 − 0.5X5) + 1
.
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We considered a tree structured true optimal regime such that
gopt1 (H1) = I(X5 > 0)× I(X1 > −0.5) + I(X1 > 0.5).
Correspondingly, the stage-wise reward was generated by
R1 = exp{1.5 + 0.003X4 − |1.5X5 − 2| × [A1 − gopt1 (H1)]2}+ ε1,












exp(0.2R1 − 0.5) + exp(0.5X1) + 1
.
The optimal decision rule for the second stage depends on the first treatment response
gopt2 (H2) = I(X2 > −1)× [I(R1 > 0) + I(R1 > 2)].
The second stage reward was generated by
R2 = exp{1.18 + 0.2X1 − |1.5X2 + 2| × [A2 − gopt2 (H2)]2}.
The target clinical outcome is the sum of two stage rewards Y = R1 +R2.
We next considered two cases of observed data. For the first case, some of the X4
entries contained error that its observed values were 100 times larger than the true
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values. The errors were generated with the following probability
P (X4 contains entry error) = 0.1I(X5 = 0)× I(weight observed in text).
Under case one, X4 contained entry error and X5 is not observed in structured EHR.
When using IE, we combined the information and obtained the full complete data.
In the second case, our structured data contained missing values such that X4 was
missing at random (MAR). The probability of missing was assigned based on X5 and
if weight information was included in the clinical notes:
P (X4 = NA) = 0.1 + 0.5I(X5 = 0)× I(weight observed in text).
Under case two, X4 was MAR in the structured data, but missing completely at
random with 10% missing when combining information extracted the from clinical
text. Similarly, X5 was not observed in structured data.
We considered a training sample of size n = 500 or n = 1, 000 and a test sample
of size n = 1, 000 for each type of data (with or without IE) under both cases. We
had 1,000 replications for each scenario. The estimated DTRs (ĝopt) were evaluated
by percentage of optimal two-stage treatment recommendations (opt%) given to the
patients in the test set. We also compared the estimated expected counterfactual
outcome denoted by Ê{Y ∗(ĝopt)} in the test set using the true rewards model.
Table 5.1 summarizes the performance of our proposed method in the simulation
studies. The cTAKES IE method successfully extracted the true smoking status
from the text messages for all patients. Thus, all scenarios with IE contains the
true smoking status variable, whereas the scenarios without IE does not have X5.
Case 1 mimicked the scenario where entry error is present for some of the structured
variables. According to Table 5.1, when n = 500, the data with IE under case
1 had significantly higher opt% (91.5% vs 58.8%) and has improved the estimated
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mean counterfactual outcome by 13% comparing to the data containing entry error
without IE. When the sample size increased to 1,000, the performance of both ĝopt
has improved while the difference remained similar. For case 2, where missingness
is involved in the body weight variable, the data with IE provides slightly smaller
opt% and Ê{Y ∗(ĝopt)} compared to the full data due to 10% random missing in X4.
However, the data with IE still significantly outperforms the data without IE across
different sample sizes.
Scenario
n = 500 n = 1,000
opt % Ê{Y ∗(ĝopt)} opt % Ê{Y ∗(ĝopt)}
Case 1 with IE 91.5 (13.4) 11.10 (0.76) 97.2 (7.4) 11.35 (0.44)
Case 1 without IE 58.8 (8.3) 9.08 (0.39) 63.1 (7.1) 9.31 (0.30)
Case 2 with IE 90.1(13.9) 10.93 (0.93) 96.3 (8.8) 11.23 (0.62)
Case 2 without IE 57.4 (10.2) 8.75 (0.77) 64.5 (7.0) 9.25 (0.53)
Table 5.1: Simulation Results. The weight variable (X4) in structured EHR contains
entry errors in case 1 and has missing values in case 2. Under both cases, the current
smoking status (X5) is not observed in structured EHR data. opt% is the percentage
of optimal treatment combinations recommended to the test sample. Ê{Y ∗(ĝopt)}
denotes the estimated expected counterfactual outcome. Standard deviations are
recorded in parenthesis.
The empirical distribution of Ê{Y ∗(ĝopt)} is shown in Figure 5.1. We observe
that for the datasets including information extracted from clinical text, most of
Ê{Y ∗(ĝopt)} were close to their optimal values. With a larger sample size (n = 1, 000),
the values were more centralized towards the optimal counterfactual outcome. The
values of Ê{Y ∗(ĝopt)} for datasets without using IE spread out around 9 and failed
to approach the optimal counterfactual outcome under the larger sample size.
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n = 500 n = 1000











Case 1 with IE
Case 1 without IE
Case 2 with IE
Case 2 without IE
Figure 5.1: Empirical distribution of Ê{Y ∗(ĝopt)} among different simulation scenar-
ios. The weight variable (X4) in structured EHR contains entry errors in case 1 and
has missing values in case 2. Under both cases, the current smoking status (X5) is
not observed in structured EHR data.
5.4 Personalized Antihypertensive Agents for Critically Ill
Patients with Severe Acute Arterial Hypertension
Severe acute arterial hypertension can have significant consequences on various or-
gans, including the heart, kidneys, brain, and lungs [81, 83], leading to life-threatening
complications. Acute arterial hypertension is commonly encountered in ICU and
acute care settings [78]. Patients with a marked increase in blood pressure and acute
severe target-organ injuries (hypertensive emergencies) often require hospitalization
in an ICU for immediate blood pressure reduction to safer levels [71]. In “hyper-
tensive emergencies”, the therapeutic strategy requires achieving careful and staged
blood pressure lowering goals within 24 hours in order to avoid sudden, excessive re-
ductions. “Hypertensive urgencies” describes the scenario when patients have severely
elevated blood pressure but are not in danger of immediate acute end-organ injury.
In this scenario, while blood pressure reduction is warranted, there are no specific
evidence-based guidelines on treatment goals. As such, clinical recommendations
typically suggest lowering blood pressure less aggressively and to aim for control over
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the ensuing few days. However, there are no absolute blood pressure thresholds that
define hypertensive emergencies or urgencies, as the actual levels differ among indi-
viduals depending on a number of characteristics including prior hypertension and
pre-existing cardiovascular health status. In general, a clinically ill patient with sys-
tolic blood pressure (SBP) levels greater than 180 mmHg or diastolic blood pressures
greater than 110 mmHg may require intervention [44].
Four classes of antihypertensive agents, including angiotensin-converting enzyme
inhibitors (ACEI), beta-blockers, calcium channel blockers (CCB), and diuretics, are
commonly used to treat hypertension. Studies suggest that antihypertensive drug
responses are heterogeneous across patients [43]. We estimated a two-stage dynamic
treatment regime to guide antihypertensive treatment for critically ill patients with
severe acute hypertension using IE and T-RL. The DTR was constructed using The
Medical Information Mart for Intensive Care III (MIMIC-III) data [34], a de-identified
EHR data with over 40,000 patients who stayed in critical care units at a large tertiary
care hospital between 2001 and 2012.
Patients with the following conditions were included in the study population: (1)
admitted to the ICU for at least 3 days; (2) had a first-day maximum SBP higher
than 180 mmHg; and (3) had been prescribed only one type of antihypertensive
agent during each stage. These inclusion criteria were selected to exclude patients
with shock, significant hypotension, and those who do not require or cannot tolerate
antihypertensive therapies. Also, we limited our population to single hypertensive
agent receivers to remove the interaction of background blood pressure medications.
Although patients were not specifically admitted with the diagnosis of a hypertensive
emergency, they had severely elevated blood pressure levels and received antihyper-
tensive treatments. Thus, we assumed that achieving tighter BP control following
the intervention is a more successful outcome.
We selected the decrease in SBP as our target clinical endpoint, which is preferable
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with a higher value. We also assumed excessive reductions of patients’ blood pres-
sure are not achievable by any single antihypertensive agent. We considered ACEI,
beta-blockers, CCB, and diuretics as possible treatments for each patient in both
stages, where ACEI, beta-blockers, and CCB were introduced orally and diuretics
were given intravenously (IV). The estimated two-stage DTR guides patients’ blood
pressure control during their first two days in ICU. Once a patient with severe acute
arterial hypertension is admitted to ICU, the DTR can recommend the most effective
antihypertensive class for the individual to use on day one (stage 1). If the maximum
SBP is still over 140 mmHg in day two, the DTR further adjusts the hypertension
treatment based on past history and further examines the patients’ SBP on day 3
(stage 2).
Studies have shown that many clinical factors, including age, family history, race,
smoking status and weight, are salient predictors of systolic blood pressure (SBP)
and significant risk factors for developing hypertension [91]. However, the MIMIC-
III structured data had no information regarding patients’ smoking status. In addi-
tion, many patients had missing values for their bodyweight upon hospital admission.
Without controlling for smoking and bodyweight, the drug effects towards SBP re-
duction might be biased in the counterfactual outcome model when estimating DTRs.
Thus, we utilized the proposed IE method to extract smoking and bodyweight infor-
mation from physician notes, discharge summaries, and general notes. We detected
common patterns in the notes for smoking status by using the named boundary de-
tector, named entity recognition, and negation annotator. For example, “X years
smoking history” and “encouraged smoking cessation” indicates current smokers,
“quit smoking X years ago” indicates former smokers, and “does not smoke” and
“denies any smoking” suggests non-smokers. We assumed patients to be non-smokers
when the smoking status was not mentioned in notes. For bodyweight, we extracted
numerical information from patterns like “weight (lb),” “wt,” and “(current): X kg.”
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After adding supplemental information from clinical notes, the study population
was summarized with 778 complete observations (see Table 5.2). The majority of
patients were in their 60s or 70s when admitted to the hospital. During the first day,
beta-blockers (42.4%) was the most commonly prescribed hypertension drug class,
followed by diuretics (31.0%), ACEI (17.6%), and CCB (9.0%). Four hundred and
forty-two patients had their blood pressure successfully controlled or stopped taking
antihypertensive drugs by the end of the first day. During the second day, a larger
proportion of the remaining patients had IV diuretics compared to the first day.
All patient characteristics listed in Table 5.2 were considered as potential tailoring
variables for the dynamic treatment regime and were included in the counterfactual
outcome model. With this study cohort, for stage 1 (day one in ICU), we found that
the optimal treatment was oral CCB for patients with maximum baseline SBP larger
than 190 mmHg and minimal creatinine larger than 2 Mg/dL. Otherwise, stage 1
optimal treatment strategy should be ACEI. If we failed to control patients’ blood
pressure during the first day in ICU, patients no older than 70 years of age should
receive oral ACEI during the second day while beta-blockers were the best hyper-
tensive agents for patients older than 70 years of age. The estimated personalized
treatment decision tree is illustrated in Figure 5.2. In fact, the DTR aligns with
the guidelines for the treatment of hypertension by the British Hypertension Society
that ACEIs are the most recommended step one antihypertensive agent for younger
patients [94]. Younger patients often respond better to ACEI therapy, potentially due
to several factors (e.g., high renin status). Additionally, high creatinine indicates pos-
sible acute or ongoing kidney function decline, and in this setting, it is not surprising
that ACEI therapy might be less effective or safe for acute blood pressure-lowering
given their potential to further drop glomerular filtration rate [75]. Thus, our results
show that patients with creatinine higher than normal levels and baseline SBP higher
than 190 mmHg might benefit more from CCB. These results can inform clinical
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Table 5.2: Descriptive Statistics of the variables among the study cohort. Note: *
mean (standard deviation) for continuous variables. Otherwise listed as n (%)
.
Stage 1 2
Total number of patients 778 336
Treatment
Oral ACEI 137 (17.6) 38 (11.3)
Oral beta-blockers 330 (42.4) 128 (38.1)
Oral CCB 70 (9.0) 23 (10.5)
IV diuretics 241 (31.0) 147 (43.8)
Age at Admission* 68.1 (14.8) 68.8 (13.9)
Female 380 (48.8) 175 (52.1)
Black 138 (17.7) 59 (17.6)
Current or Former Smoker 506 (65.1) 217 (64.6)
Weight (lb)* 176.5 (59.7) 173.2 (55.1)
Kidney disease 140 (18.0) 59 (17.6)
Diabetes 336 (43.2) 142 (42.3)
COPD 38 (4.9) 20 (6.0)
Chronic Hypertension 369 (47.4) 150 (44.6)
Daily Max Systolic BP* 196.6 (16.0) 181.6 (26.7)
Daily Max Diastolic BP* 100.6 (24.1) 91.9 (24.2)
Heart Rate* 80.8 (15.3) 81.3 (14.8)
Temperature (C)* 36.9 (0.6) 37.0 (0.6)
Oxygen Saturation* 97.1 (1.9) 97.0 (1.8)
Daily Maximum Hemoglobin* 11.7 (2.0) 11.6 (13.9)
Daily Minimum
creatinine (Mg/dL)*
1.8 (2.0) 1.6 (1.6)
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practice, pending the results of randomized clinical trials. We further compared the
decrease in SBP for the study population under the estimated dynamic treatment
regime versus the observed treatment experiences. If the estimated treatment regime
were followed, 67.8% of the patients in our study sample would have better control
of SBP during their first two days in ICU.
Figure 5.2: Estimated optimal dynamic treatment regime for blood pressure man-
agement among critically ill patients with severe acute hypertension. The optimal
DTR was estimated using T-RL with extra information extracted from IE. Stage 1
indicates time from the first day to the second in ICU and stage 2 indicates time from
the second day to the third day in ICU.
We further compared the counterfactual outcomes for our test set under the esti-
mated optimal treatment regime versus the observed treatment experiences. Overall,
the improvement in estimated mean counterfactual systolic blood pressure is 1.40
mmHg if the patient received the optimal treatment according to our estimated treat-
ment decision rule compared to the observed data. If the estimated treatment regime
were followed, 64.5% of patients in our test set would have their outcome improved .
5.5 Discussion
We have evaluated the benefit of using IE techniques to extract information from
free-text clinical observations when estimating optimal DTRs. Our approach can
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effectively alleviate problems in the structured EHR data, including missing values,
erroneous entries, and unobserved risk factors. Our experiments show that the T-
RL method significantly benefits from the use of IE. This strategy enables clinical
decision support for larger study populations, provides more accurate counterfactual
outcome modeling, and supports a wider pool of candidate tailoring variables.
However, the improvement of DTR estimation largely depends on the quality
of clinical free-text and the IE technique. The benefit of IE may be limited when
there is little additional informative content embedded in the clinical free-text. We
employed a rule-based IE technique in this chapter. Since none of the IE techniques
offers perfect accuracy, some of the extracted information may introduce bias to the
final treatment regime. Moreover, for the rule-based IE techniques, scalability might
be a potential issue when the number of variables to extract is large. Future studies
might consider robust methods like deep learning techniques for extensive information
extraction in a large text corpus when estimating optimal DTRs.
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CHAPTER VI
Summary and Future Work
This dissertation has addressed three challenges in biomedical researches involving
complex observational data: secure data sharing, viable optimal DTR estimation, and
handling free-text data. The proposed techniques are designed to provide robust and
scalable solutions.
The DataSifter framework proposed in Chapter II (DataSifter I and II) and Chap-
ter IV (DataSifterText) is an essential addition to the literature of partially synthetic
data generation. It provides a single synthetic dataset with global data desensiti-
zation and enables user-specified obfuscation levels. For structured data, compared
to the state-of-the-art multiple imputation method, DataSfiter achieves better pro-
tection in data privacy disguising the location of obfuscated and untreated data el-
ements. For unstructured data, DataSifterText offers better data utility by filling
in similar contents in the “masked” locations compared to the conventional token
suppression method. The DataSifter and DataSifterText algorithms are implemented
in R, allowing flexible parallel computing setup. The corresponding R packages are
available on The Statistics Online Computational Resource (SOCR) GitHub directory
https://github.com/SOCR.
In Chapter III and Chapter V, we have explored practical methods for improv-
ing the quality of optimal DTR estimation using observational data. The RT-RL
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method proposed in Chapter III accommodates restrictions on feasible treatment
combinations in observational studies. It offers a constrained optimization procedure
for effectively seeking viable optimal DTR among a subset of possible DTRs, facili-
tating the interpretability of DTRs for physicians to understand and use in practice.
Chapter V advocates the utilization of unstructured information in optimal DTR es-
timation. We evaluated the benefit of IE on enlarging sample size, handling missing
data, and widening the pool of candidate tailoring variables.
Some extensions can further enhance the flexibility and performance of the pro-
posed methods. The current version of DataSifter II assumes that the time intervals
between visits are similar across patients. It is of interest to handle the scenario
when we have unequally spaced time-varying data across patients. Future studies
may also consider introducing different variable importance among variables during
the DataSifter obfuscation procedure. In this case, artificial missingness and obfusca-
tion can occur with a higher probability in user-defined important variables to adapt
various data de-identification tasks. Moreover, for free-text obfuscation, a valuable
extension is to improve the semantic similarities between the observed and sifted text
given a specific obfuscation level. This extension would involve training a complex
machine that understands both individual word tokens and grammar structures of
the original text. Finally, due to the global surge of COVID-19 cases and our limited
knowledge about the virus, patient data privacy protection could be an important
issue that affects both the treatment development and the patients’ right. Obfuscat-
ing patient records with the DataSifter algorithm could be a potentially impactful
application to alleviate the problem.
One important future research direction on RT-RL is to extend the restrictions
on observed patient characteristics in addition to treatment combinations. Thus, we
can impose corresponding restrictions on the viable treatment set for patients with
specific characteristics (e.g., lab test results). Furthermore, when applying IE tech-
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niques in optimal DTR estimation, we may consider automated information extrac-
tion methods, including deep learning, rather than rule-based algorithms, to alleviate
the scalability issue when the number of variables to extract is large. We used T-RL
to make interpretable treatment decisions in a clinical setting with extra information
provided by IE. Future studies can also consider combining deep reinforcement learn-
ing and IE to make adaptive decisions when interpretability is not a concern. For
example, in a mobile health setting where wearable devices collect vocal and physical
information from patients, a deep reinforcement learning machine can cooperate with
IE to understand vocal information and suggest proper interactions with the users.
The general theoretical formulation of the methods leads to the design of tools and
direct applications that are expected to go beyond the biomedical and health analytics
domains. For instance, the DataSifter framework can be generalized to handle sensi-
tive datasets in socioeconomic, environmental, and insurance domains. In addition,
viable optimal DTR estimating procedures have possible extensions on managing cli-
mate change, factory production and inventory, air traffic control, firefighting, and





Proofs for Chapter III
Proposition 1 (Double Robustness). Assume patient observations
{Xi,Ai,(T−1), Ai,T , Yi}ni=1 are independent and identically distributed that follows cer-
tain multivariate distribution p. A subset of nres,T patients have viable past treatment
routes until stage T . We define viable patient observations as {HresiT , AiT , Yi}n
res,T
i=1 ≡
{Xi,Ai,(T−1), AiT , Yi}n
res,T
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